Apr Jun 2013
Apr Jun 2013
ISSN 1993-2863
Official Journal of Peshawar Medical College
INTERNATIONAL
INTERNATIONAL
Q ORIGINAL ARTICLES
Q CASE REPORT
Q REVIEW ARTICLES
Q GENERAL SECTION
Q OPHTHALMOLOGY NOTEBOOK
RP, AMD and allied disorders. Regenerative Medicine under the guidance of Prof. Emeritus Dr. N. M. Butt, a
is no doubt a nascent yet a burgeoning field of renowned atomic scientist as its chairman. Any student
Ophthalmology, certainly not insurmountable. interested in the field of Nano-science can join such
According to Prof. Marco A. Zarbin, PhD., Institute of institution. Recently, Quaid-e-Azam University,
Ophthalmology and Visual Science, University of Islamabad held an international conference on Nano-
Medicine & Dentistry of New Jersey., “Biodegradable science & Technology. Eminent teachers from Pakistani
(poly) lactic-co-glycolic Acid (PLGA) microspheres and foreign Universities participated in the conference,
loaded with intra-vitreal glial-derived neuro-trophic discussing the impact this technology on vast number
factor (approved by FDA for human use) provides of fields and the future prospects of applications in
sustained ganglion cell protection in Glaucoma. The Pakistan. Another tripartite seminar was jointly
prospects are very exciting for the physicians solving organized by the Preston Institute of Nano-Science &
their multi-faceted problems by offering a control over; Technology (PINSAT) and the International
how molecules interact with one another in giving them Development Research Centre (IDRC) Canada, in which
ability to respond to their environment with sapient scientists from Sri Lanka, India and Pakistan strongly
behaviour. emphasized that Pakistan should seriously consider
In fact, nano-materials have large surface area to development of Nano technology manpower in the
interact and to bring a chemical reaction. They have country.
altered functionality like 100 times stronger than steel In this context, Ophthalmology Update can also
and can melt gold at room temperature. It has a provide guidance to young aspirantswho wish to
molecular self-assembly basically putting molecules specialize in the progressive field of Medicine especially
where you want them to be, what you want them to do in Nano-Ophthalmology, which will provide them
and when you want them to do. Nano-technology is invaluable opportunities to diagnose and treat their
the art of designing and building machines in which patients on better lines. Ophthalmic medicine of the
the specifications are determined down to molecule. The future could find new tools for the problems considered
technology is very cost-effective allowing mass intractable. The application of this rapidly growing field
production at a lowest cost even for a therapyof longer will ultimately ensuring the healthful longevity of life.
duration by delivering minute quantities to precise
target having few or no side effects. Dr. Madiha Durrani
Pakistan has already entered into the field of MBBS., MCPS., FRCS.
Nanotechnology and it is very encouraging to learn that Ophthalmic Surgeon & Associate Editor
the Preston University in Islamabad has started a BS – Dubai, UAE.
4 years degree course at undergraduate degree level at E. Mail> [email protected]
the Institute of Nano-science & Technology (PINSET)
OBITUARY
The whole medical community in general and the ophthalmic community in particular is deeply
shocked at the sad and sudden demise of Prof. Ali and his son. They were brutally martyred recently
in Lahore.
Dr. Syed Ali Haider was the only son of Prof. Zafar Haider and Professor Tahira Bokhari. He
graduated from K.E.M.C in 1987 and proceeded to the UK to complete his FRCS in Ophthalmology.
He returned to serve his country with dedication and devotion. Prof. Ali had a brilliant record of
academic eminence in pursuit of knowledge in the field of Ophthalmic Sciences. It speaks volumes
of his creditable contributions to take the Pakistan Journal of Ophthalmology to enviable heights as
the Editor in Chief. He worked very hard to achieve professional excellence and earned a prestigious
place in the Ophthalmic community as Professor of Ophthalmology and a venerated academician
at Lahore General Hospital.
Dr. M Afzal Bodla from Multan knows him from the very childhood as a student at Nishter
Medical College, Multan, as he grew with all capabilities of his father Prof Syed Zafar Haider. Besides
these qualities of head and heart he was an extraordinary human being and a soft spoken gentleman.
We pray that God may give courage to the family to face this irreparable loss.
According to Dr. Syed S. Hasnain from California USA, he is survived by his wife, a teenaged
son and a six month old daughter. He will be sorely missed by his family, friends, relatives, and
thousands of patients. May Allah grant him peace in paradise.
The brotherly Afghan ophthalmologists have expressed their profound grief over the untimely
death of Prof. Ali Haider at a very young age. He was extremely kind and caring to the Afghan
patients being referred to him for vitreo-retinal consultation.
The management and the editorial board Ophthalmology Update offer sincerest condolences
to his family, his students, colleagues and whole ophthalmic community.
ABSTRACT
Background: Computerized recording and analysis of conventional colour vision test results is desirable, and software
has been developed for colour matching tests. However, the need exists for such software for pseudo-isochromatic plate
tests (PIPT).
Methods: A software written in Microsoft Visual Basic for the purpose of recording and interpretation of conventional
PIPT results is described in detail.
Conclusion: The prototype software has a potential to be utilized in routine clinical practice and epidemiological studies,
and the large amount of data thus obtained may be efficiently recorded, interpreted and archived in short time and with
very few resources.
Key Words; Colour Vision, Computers in Medicine, Optic nerve
Ishihara [38 plate Edition – 1973, Kanehara Shuppan test is entered in the retrieval box and the retrieval
Co., Ltd. Tokyo, Japan] and the first 25 plates are taken button clicked.
as the standard test. Interpretation of response as INTERPRETATION
normal, specific abnormal, or non-specific abnormal is If a response to a slide is incorrect and specific to
done by the application after matching each response any known type of CV deficit, the fact is mentioned by
according to the information in the booklet provided the software on the result screen beside that plate
with the test book. number, otherwise this is remarked as ‘Incorrect: Non
The software is distributed as a zipped file, named: Specific’. The correct response is remarked ‘Correct’.
“Rizvi’s CVR&AS.zip” contents of which are first Figure 1 shows the test results of a Red-Green deficient
extracted in a known folder. The ‘Setup.exe’ file in that person
folder is then clicked to complete the installation DISCUSSION
process. Minimum screen resolution required is 1024 X Computer assisted analysis of the results of a
768 pixels. In windows 7, writing “rizvi” in the program conventional test is not a new idea. The most familiar
search box will retrieve the application, and in windows example is the software developed for the Farnsworth-
XP it will be listed in the start program menu. The Munsell 100 Hue test.8 Recording and computation of
software can be obtained free of charge via email to the results in the PIPTs is not as complex as in the FM 100
corresponding author or downloaded from the Hue test, yet software for these tests is needed because
following link: http://rapidshare.com/files/633714883/ they are performed far more frequently in clinical
Rizvi’s CVR%26AS.zip practice. This prototype software was based on the
The start page offers the option of either starting Ishihara PIPT, but it can be written for any PIPT using
a new test, or retrieval of results of a test done the same principle.
previously. This software is quite comprehensive, but there is
For the new test, the patient’s particulars are much potential for upgrading. e.g. a database software
entered and the button captioned ‘Start Test’ is clicked. can be incorporated, making the test very useful for
The second screen then appears, where there are 25 epidemiological studies, and can be carried out even
buttons on the left of the screen representing the first by non medical personnel, e.g., school teachers.
25 plates in the Ishihara PIPT in sequence. The standard Similarly, the results can be linked to the patient’s
Ishihara book is given to the patient and the electronic MR, which is rapidly becoming the standard
conventional test is started. When the patient gives the of medical record keeping.
response to the fist plate, the button no. 1 is clicked and CONCLUSION
the patient’s response entered in the entry box, which At present, the images of the PIPT appearing on
appears beside the button. This is repeated for the rest the computer screen are solely for identification purpose
of the 25 plates. At each button press, an image of the for the examiner, the test being carried out
corresponding plate appears on the computer screen, conventionally as usual. However, personal computer
which is only for the examiner, to make sure that the monitor is being evaluated as a potential medium for
correct sequence of plates is entered. At the completion the patient to discriminate the colours.9, 10If significant
of the test the ‘FINISH’ button at the bottom of the evidence of the accuracy of this method becomes
screen is clicked, which leads to the final results screen. available, the need for the conventional printed plates
The results contain the patient’s response, the correct may be obviated completely after standardization and
answer, and the interpretation of each plate. The overall calibration of the color display in the computer monitor.
score is also mentioned as number of plates correctly REFERENCES
identified. The examiner gives the results a file name 1. Shoji T, Sakurai Y, Sato H, Chihara E, Takeuchi M. Do type 2
diabetes patients without diabetic retinopathy or subjects
in the appropriate box, to be saved for the future with impaired fasting glucose have impaired colour vision?
reference. If desired, comments are entered in the The Okubo Color Study Report. Diabet Med. 2011;28(7):865-
‘Comments’ box. A print out can be taken at this stage 71.
to be included in the patient’s medical record (MR) file. 2. Oh YS, Kim JS, Chung SW, Song IU, Kim YD, Kim YI, et al.
Color vision in Parkinson’s disease and essential tremor. Eur
Any file name can be allotted to a test result but it is J Neurol. 2011;18(4):577-83.
useful to include the patients MR number and the date 3. Shaygannejad V, Golabchi K, Dehghani A, Ashtari F,
on which the test was performed. For example, the file Haghighi S, Mirzendehdel M, et al. Color blindness among
name for a test performed by a patient with a MR multiple sclerosis patients in Isfahan. J Res Med Sci.
2012;17(3):254-7.
number ‘123abc’ on the 12th of June 2012 can be ‘123abc- 4. Hyon JY, Lee JH, Wee WR. Shift of colorimetric values in
120612’. All the files are saved in the installation ishiharapseudoisochromatic plates with plate aging. Korean
directory by default. J Ophthalmol. 2005;19(2):145-8.
For retrieval of prior results, the file name for that 5. Birch J. Identification of red-green colour deficiency:
sensitivity of the Ishihara and American Optical Company 8. Hidajat RR, Hidayat JR, McLay JL, Elder MJ, Goode DH,
(Hard, Rand and Rittler) pseudo-isochromatic plates to Pointon RC. A fast system for reporting the Farnsworth-
identify slight anomalous trichromatism. Ophthalmic Physiol Munsell 100-hue colour vision test. Doc Ophthalmol.
Opt. 2010;30(5):667-71. 2004;109(2):109-14.
6. Cole BL, Lian KY, Lakkis C. The new Richmond HRR 9. Rabin J, Gooch J, Ivan D. Rapid quantification of color vision:
pseudoisochromatic test for colour vision is better than the the cone contrast test. Invest Ophthalmol Vis Sci.
Ishihara test. ClinExpOptom. 2006;89(2):73-80. 2011;52(2):816-20.
7. Lim SA. Ethambutol-associated optic neuropathy. Ann Acad 10. Toufeeq A. Specifying colours for colour vision testing using
Med Singapore. 2006;35(4):274-8. computer graphics. Eye (Lond). 2004;18(10):1001-5.
in visual status was observed in 6 (13.95%) . In a study photocoagulation in rabbits, Yonsei Med j 36:243-250,1995.
done by Garthy et al best corrected visual acuity was 5. Hilton, GF: Subretinal pigment migration: effect of
cryosurgical retinal reattachment, Arch Ophthalmol 91: 445-
improved in 92 eyes (81%), unchanged in 14(12%), and 450, 1974.
worse in eight (7%) after PPV.13 6. Sudarsky,RD,and Yannnuzzi,LA: Cryomarcation line and
In our study those patients who received cryo to migrationafter retinal cryosurgery, Arch ophthalmol 83:395-
the break during PPV, the vision improved in 17 401, 1970.
7. Campochiaro,PA,Kaden, IH, Vidurri-Leal, and Glaser, BM:
(40.47%) patients and deteriorated in 15 ( 35.71%). No Cryotherapy enhances intravitreal dispersion of viable retinal
improvement or loss was recorded in 10 (23.80%) eyes. pigment epithelial cells, Arch Ophthalmol 103:434-436,1985.
This is almost similar to the study by Brazitikos in which 8. Oosterhuis, JA, Brihaye, M, AB: A comparative study of
the mean and final best-corrected visual acuity (log experimental transscleral cryocoagulation by solid carbon
dioxide and diathermocoagulation of the retina
MAR) was 0.33 in the PPV group with cryopexy 14. Our ,Ophthalmologica 156:38-78, 1999.
study result does not reveal significant difference in the 9. Jaccoma, EH: Conway, BP and Compochiaro,PA: cryotherapy
two groups but the literature is quite deficient in such causes extensive breakdown of the blood retinal barrier: a
comparisons of these two adhesive procedures. comparison with argon photocoagulation, Arch Ophthalmol
103: 1728-1730, 1985.
CONCLUSION 10. Ackerman, AL, and Tiplow, HW: A reduce incidence of
Endolaser retinopexy around the tear is relatively cystoid macular oedema following retinal detachment
easy to perform for retina surgeons. Endolaser and surgery using diathermy, Ophthalmology92:1092-1095,1985.
cryopexy around the tear after pars plana vitrectomy 11. Yeh PT, Yang CM, Yang CH, Huang JS. Cryotherapy of the
anterior retina and sclerotomy sites in diabetic vitrectomy to
and internal tamponade has no significant difference prevent recurrent vitreous hemorrhage: an ultrasound
regarding affect on the visual outcome. biomicroscopy study. Ophthalmology. 2005
REFERENCES: Dec;112(12):2095-102. Epub 2005 Oct 12.
1. Yoon,YH and Marmor,MF: rapid enhancement of retinal 12. Kwok AK, Cheng LL, Gopal L, Sharma T, Lam DS. Endolaser
adhesion by laser photocoagulation,Ophthalmology 95:1385- around macular hole in the management of associated retinal
1388,1988. detachment in highly myopic eyes.Retina. 2000;20(5):439-44.
2. Kita,M, Negi, A,Kawano,SI,and Honda,Y:Photothermal, 13. Garthy DS,Chingnell AH, Frank and WA, Wang D.Pars plana
cryogenic,and diathermic effect on retinal adhesive force in vitrectomy for the treatment of rhegmatogeous retinal
vivo, Retina 11:441-444,1991. detachment uncomplicated by advance proliferative
3. Kita,M, Negi, A,Kawano,SI,and Honda, Y and Meagawa, S: vitroretinopathy. Br J Ophthamol 1993:77 199-203.
Measurment of retinal adhesive forces in the vivo rabbit eye, 14. Brazitkos, Periklisd, Androudi,Sofia,Christen,Willaim G,
Invest Ophthalmol Vis Sci 31:624-628,1990. Nikolaos TR.Primary pars plana vitrectomy vesus scleral
4. Kwon,OW, and Kim, SY:Changes in adhesive forcebetween buckle surgery for the treatment of puedophakic retinal
the retina and the retinal pigment epithelium by laser detachment. Retina 2005 : 957-965.
Please Contact:
Dr. Mir Ali Shah
General Secretary
Ophthalmological Society of Pakistan
Peshawar. Khyber Pukhtoonkhwa
Cell: 0300-5948091
ABSTRACT
Objective: This study was conducted to evaluate the effectiveness of using topical antihistamine (pheniramine maleate)
and decongestant (naphazoline) eye drops in reducing the severity and complications of adenoviral conjunctivitis during
an epidemic.
Study design: Randomized controlled trial (RCT)
Place and duration of study: Three months study from June 2012 to august 2012 was conducted at ophthalmology
department, Combined Military Hospital, Abbottabad.
Patients and Method: A total 1570 cases of adenoviral conjunctivitis were documented during the months of June, July
and august 2012. By simple randomization 200 patients were selected and divided into two groups on the basis of
treatment. Group 1 (treatment group) 40% patients were given topical antihistamine and decongestant drops whereas
Group 2(control group) 60% patients were managed conservatively by washing eyes with cold water and applying ice
packs on the eyes.
Results: In most cases (90%) both eyes were affected. Acute illness lasted from4.50 days in group1 and 7.65 days in
group2. Commonly observed symptoms included redness, watering, itching, burning and pain in the eyes and photophobia.
The duration of illness was less and the severity was mild in group1 as compared to group2 patients. This was found to be
statistically significant using Chi-square test (p<0.05). None of the case reported any complication after recovering from
the infection.
Conclusion: Adenoviral conjunctivitis is a highly contagious disease and often spreads in epidemics particularly in crowded
communities with poor hygiene. Prevention of the transmission is the most important therapeutic measure. Although the
disease is benign and self-limiting, the use of topical antihistamine and decongestant drops markedly reduce the severity
and duration of the symptoms.
Keywords: adenoviral, epidemic, antihistamine, decongestant
the disease was seen in the month of July 2012 when 4. Smolin G, Thoft RA: Viral Keratitis and Conjunctivitis.In:
humidity was at its peak. In 90% cases both eyes were Cornea:Scientific Foundations and Clinical Practice.3 rd
edition. Boston. Little Browns &Co. 1994;215-22.
affected. Most commonly observed symptoms were 5. Buerhler JW, Finton RJ, Goodman RA, Choi K, Hierholzer jc,
redness of eyes, watering, itching, burning, Sikes RK, et al. Epidemic Keratoconjunctivitis report of an
photophobia and pain in the eyes. Duration of the illness outbreak in an ophthalmic practice & recommendations for
as well as severity of the symptoms was mild and prevention. Infect Control 1984;5:390-4.
6. Wilhelmus KR. Viral infections. In: American Academy of
statistically significant in group 1 patients as compared Ophthalmology Basic & Clinical Science Course (section 8)
to group 2 (p < 0.05). Results were comparable with 1999;136-40.
similar studies of Buerhler et al and Rosenbach et al.5,16 7. Wright KW, Liesegang TJ: Conjunctiva. In: Textbook of
CONCLUSION Ophthalmology. First Edition. Baltimore: Williams & Wilkins
1997;665-90.
Adenoviral conjunctivitis is a highly contagious 8. Darougar S, Quinlan MP, Gibson JA et at: Epidemic
disease and often spreads in epidemics particularly in Keratoconjunctivitis and chronic papillary conjunctivitis in
crowded communities with poor hygiene. It is London due to adenovirus type 19. Br J Ophthalmol 1977;665-
extremely important to teach the masses about the 90.
9. Sarangapani S and Corbet MC: Stellate tarsoconjunctival
nature of disease, treatment and prevention of its lesions in ocular adenoviral infection. Br J Ophthalmol
spread. Prevention of transmission is the most 2002;86:594.
important therapeutic measure by avoiding close 10. Leibowitz HM, Waring GO: Superficial punctuate
contact of the affected person and not sharing towel keratopathy. In: Clinical Disorders of eye: Clinical Diagnosis
and Management. 2nd edition. St. Louis CVV. Mosby & Co.
used by him. In the ophthalmic clinics of the hospitals 1998;445-7.
hands must be washed with soap and water before and 11. Hodge W, Wohl T, Whitcher JP, Margolis TP. Corneal sub-
after examining the patient. Thorough sterilization of epithelial infiltrate recurrence with adenovirus. Cornea
instruments touching the patient’s eye must be carried 1995;14:324-5.
12. Petit TH, Holland MM: Chronic keratoconjunctivitis
out and frequent changing of multi use eye drops is associated with ocular adenoviral infection. Am J Ophthalmol
extremely important. 1979;88:748-51.
Although the disease is benign and self limiting, 13. Uchio F, Takeuchi S, Itoh N, Matsuura N, Ohno S, Aoki K.
cold compresses and topical antihistamine and Clinical and epidemiological features of Acute Follicular
Conjunctivitis with special reference to that caused by herpes
decongestant eye drops markedly reduce the simplex virus type 1.Br J Opthalmol 2000;84;968-72.
discomfort, severity and duration of the adenoviral 14. Mellman-Rubin TL, Kowalski RP, Uhrin M, Gordon YJ.
conjunctivitis during an epidemic. Incidence of adenoviral,chlamydial coinfection in acute
REFERENCES follicular conjunctivitis. Am J Ophthalmol 1995;119:652-4.
1. Krashmer JH, Mannis MJ, Holland E: Conjunctivitis: an 15. Gordon JS: Adenovirus and other non-herpetic viral diseases.
overview and classification of viral conjunctivitis. Cornea In: Smolin G, Thoft RA (ed): The Cornea.Third Edition.
1995;5:750-51, 773-4. Boston: Little Brown & Co 1994;215-27.
2. Kaufman HE, Barron BA, Me Donald MB; Nonherpetic viral 16. Rosenbach KA, Nadiminti U, Vincent AL et al: An outbreak
infections, Cornea 1998;1:303-6. of adenoviral keratoconjunctivitis. Infect Med 2002;19:436-
3. Tasman W, Jaeger EA: Epidemic keratoconjunctivitis. 8.
Duanne’s Clinical Ophthalmology 1998;4;5-8
Update
Approved & indexed by PMDC, PakMedinet & H.E.C
ABSTRACT:
Objectives: The objectives of the study were to find out the frequency of Amblyopia and post operative ocular alignment
of squint patients.
Material and Methods: This prospective study was conducted in Eye A ward of Khyber Teaching Hospital Peshawar from
1st Jan 2012 till 30th Oct 2012. Patients were examined over 9 months.
The details of each patient were recorded by orthoptist pre operatively and then at approximately 1 week interval post
operatively. At each visit a full orthoptic assessment was done including visual acuity, prism cover test, and assessment
of binocular single vision using tests appropriate for the age. Other parameters were also recorded by orthoptist but have
not been analyzed in this study. Eyes with alignment of 10 prism diopters were considered as straight and all the rest
would be considered as misaligned.
Results: Total of 115 patients were analyzed pre operatively. Out of these 115, 92 patients (80%) were esotropic of which
63 (54.78%) were of unilateral esotropia and 29 (25.22%) were of alternating esotropia. Remaining 24(20%) were of
exotropia of which 13 patients (11.30%) were of unilateral exotropia and remaining 11 (9.56%) were of alternating exotropia.
Of these pre operative patients 54(46.91%) were males and 61(53.04%) were females. There were total of 35 patients up
to 10 years of age(30.43%), from 10-16 years were 33(28.70%),from 16-25 years were 34(29.56%) and above 25 years
were 13(11.30%) in number. Patients in whom complete post operative assessment was done were 95 in number and rest
were lost in follow up.
Out of these 95 patients that have been assessed post operatively 85(89.47%) patients were having straight eyes
at 1 week post operatively i.e., deviation within 10 prism diopters of straight, residual squint was found in 8 patients
(8.42%) and consecutive squint was found in 2(2.11%) patients. Out of 115 patients, 38(33.04%) patients were having
amblyopia. Amblyopia was checked by visual acuity chart (Longmar visual acuity chart, Snellen chart and correction of
refractive error). Stereopsis was absent both pre and post operatively in 44(46.32%) checked by Titmus Fly test, Lang
test, Frisby test. Suppression and post operative diplopia was checked by Worth four light test and Bagolini test.
Conclusion: The study shows that most of patients with unilateral squint were having amblyopia, having frequency
33.04%. The results of squint surgery were satisfactory. The ratio of female was greater than male.
Key Words: Amblyopia, Residual Squint, Consecutive Squint
image with glasses, and/or encouraging use of the Result of Squint surgeries
amblyopic eye with an eye patch over the dominant
eye or pharmacologic penalization of the better eye. S.No Postoperative Status Quantity Percentage
Penalization usually consists of applying atropine drops 1 Straight Eyes 85 89.47%
to temporarily dilate the pupil, which leads to blurring
2 Residual 08 8.42%
of vision in the good eye. This helps to prevent the
bullying and teasing associated with wearing a patch, 3 Consecutive 02 2.11%
although application of the eye drops is more Total 95 100%
challenging. The ocular alignment itself may be treated
with surgical or non-surgical methods, depending on
Frequency of Amblyopia
the type and severity of the strabismus8.
MATERIALS AND METHODS
This prospective study was conducted in Eye A-
ward of Khyber Teaching Hospital Peshawar from 1st
February 2012 till 30 the October 2012. Patients were
recruited over 9 months. One surgeon was asked to
indicate the intended post operative surgical alignment.
The decision was based on the clinical judgment of
surgeon involved. Since only the accuracy of ocular
alignment was being analyzed, no attempt was made
to standardize the surgical objectives or techniques
among the participating surgeons. 38(33.04%) patients were having amblyopia.
The details of each patient were recorded by DISCUSSION:
orthoptist pre-operatively and then at approximately 1 In our study total 115 patients of squint were
week interval post operatively. At each visit a full examined. Out of them, 95 were post operatively
orthoptist assessment was done including visual acuity, examined. The frequency of Amblyopia was 33.04% (38)
prism cover test at 1 meter, and assessment of binocular patients. The successful results of squint surgery were
single vision using tests appropriate for the age. Other 89.47% (85) patients (having post operatively straight
parameters were also recorded by orthoptist but have eyes). Residual squint was 8.42% (8) patients. 2.11%
not been analyzed in this study. Eyes with alignment were having consecutive squint (2) patients.
of 10 prism diopters of straight would be considered as Out of 115 patients, 54 (46.91%) Patients were male
straight and all the rest would be considered as 61(53.04%) were female.
misaligned. The success or failure of a surgical approach can’t
RESULTS: be evaluated within a short follow-up period. The
Total of 115 patients were analyzed pre consecutive exotropia may not develop until years after
operatively. Out of these 92 patients (80%) were the surgery for esotropia. However our study was based
esotropic of which 63 (54.78%) were of unilateral on short follow-up period.
esotropia and 29 (25.22%) were of alternating esotropia. Two patients had large angle esotropia and
Remaining 24(20%) were of exotropia of which 13 bilateral medial rectus recession was done and results
patients (11.30%) were of unilateral exotropia and were residual esotropia. In our study there were two
remaining 11 (9.56%) were of alternating exotropia. Of patients (2.11%) with consecutive squint. According to
these pre operative patients 54(46.91%) were males and a study the incidence of consecutive exotropia ranged
61(53.04%) were females. There were total of 35 patients from 4%9 to 20%10. A study done in Korea shows that
up to 10 years of age(30.43%), from 10-16 years were consecutive esotropia developed in 13.8% of patients
33(28.70%),from 16-25 years were 34(29.56%) and above with immediate overcorrection of at least 17 PD.11 A
25 years were 13(11.30%) in number. Patients in whom study done in Department of Ophthalmology and Lions
complete post operative assessment was done were 95 Eye Institute, Albany Medical College, Albany, New
in number and rest were lost in follow up. York USA shows 60% successful result (straight eyes)
Out of these 95 patients that have been assessed 32% residual esotropia and 8% consecutive exotropia.12
post operatively 85(89.47%) patients were having In our study (71.58%) were children. A study done in
straight eyes at 1 week post operatively i.e., deviation London shows infants undergo early surgical
within 10 prism diopters of straight, residual strabismus intervention, they have a chance of better alignment and
was found in 8 patients (8.42%) and consecutive squint stereopsis outcomes. Multiple surgeries may be needed
was found in 2(2.11%) patients. Out of 115 patients,
to correct large angle of the esotropia. The number of Outcomes of Horizontal Strabismus Surgery and Influencing
children requiring a second operation varies between Factors of the Surgical Success. J Med Assoc Thai 2005; 88
(Suppl 9): S94-9
15-30%.13 5. Scott WE, Reese PD, Hirsh CR, Flabetich CA. Surgery for
Another study done on comitant esotropia shows, large angle congenital esotropia. Arch Ophthalmol 1986; 104:
close follow-up was required especially in cross fixating 374-7.
children as amblyopia in one eye usually presents after 6. Simonsz HJ, Kolling GH, Unnebrink K .Final report of the
early vs. late infantile strabismus surgery study (ELISSS), a
surgical alignment.14 controlled, prospective, multicenter study. 2005; 13(4):169–
A study done on surgical management of residual 199.
or recurrent esotropia shows that difference in surgical 7. Wright, Kenneth W.; Spiegel, Peter H.; Thompson, Lisa S.
response per millimeter of unilateral lateral rectus (2006). Handbook of Pediatric Strabismus and Amblyopia.
New York, New York: Springer. ISBN 978-0387-27924-4.
resection were not significant. Bilateral lateral rectus 8. Holmes, Repka, Kraker & Clarke (2006). “The treatment of
resection of 5, 6 and 7 mm resulted in a mean correction amblyopia”. Strabismus 15(1): 37-42. Doi: 10, 1080/
of 19.75, 28.75 and 33.05 prism diopters, respectively.15 09273970500536227. PMID 16513568.
A study done on bilateral lateral rectus resection 9. Bietti GB, Baglioni B. Problems related to surgical
overcorrections in strabismus surgery. J Pediatr ophthalmol
in patients with residual esotropia, showing successful 1965; 2:11-4.
alignment in 68% under correction in 28% and 10. Dunnington JH. Regan EF factor influencing the
overcorrection in 4% cases, six month after surgery.16 postoperative result in concomitant convergent strabismus.
In our study the frequency of amblyopia was (33.04%) Arch ophthalmol 1950; 44:813-22.
11. Yoonae A.Cho, MD. Department of Ophthalmology, Anam
which is quite different from, a study done in Hospital, College of Medicine, Korea University.January 25,
Department of Ophthalmology, Postgraduate Institute 2007; Accepted August 02, 2007.
of Medical Education and Research, Chandigarh, India 12. Gunasekera LS, Simon JW, Zobal-Ratner J, Linninger LL.
shows the frequency of amblyopia were 61.3%.17 Department of Ophthalmology and Lions Eye Institute,
Albany Medical College, Albany, New York 12208, USA.
CONCLUSION: 2002 Fab; 6(1): 21-5.
The study shows that most of patients with 13. Elston J. Concomitant strabismus. In: Taylor D. Pediatric
unilateral squint were having amblyopia, with ophthalmology. 2nd ed. London: Blackwell sciences: 1997.
frequency of 33.04%. The results of squint surgery were p. 925-36.
14. Raab EL, comitant esotropia. In: Wilson ME, Sunders RA,
good. Trivedi RH. Pediatric Ophthalmology: current thoughts and
The ratio of female was greater than male. The practical guide. Leipzig. Springer: 2009. p. 85-112.
ratio of unilateral esotropia was greater than alternating 15. David G. Morrison, MD; Matthew Emanuel, MD; Sean P.
esotropia, and the ratio of esotropia was greater than Donahue, MD, PhD. Surgical management of residual or
recurrent esotropia following maximal bilateral medial rectus
exotropia. recession free. Arch Ophthalmol. 2010; 129(2): 173-175.
REFERENCES: 16. Gyu Jin Jng, MD, Mi Ra Park, MD, Soo Chul Park, MD.
1. Arora A, Williums B, Arora AK. Decreasing strabismus Bilateral lateral rectus resection in patients with residual
surgery. Br J Ophthalmol 2005; 89: 409-12. esotropia. Department of Ophthalmology, St. Mary’s
2. Cooper J, Medow N. Major review, Intermittent Hospital, Kngnam St. Mary’s Hospital, School of Medicine,
exotropia,Basic and Divergence Excess Type.Binocular Vision The Catholic University of Korea, Seoul, Korea. Korean J
Eye Muscle Surgery Qtrly 1993;8: 185-216. Ophthalmol 2004; 18: 161-167.
3. Willshaw HE, Keenen JM. Strabismus surgery in children: 17. Kanwar Mohan MS, Ashok Sharma MS, S.S Panday MS.
the prospects for binocular single vision. Eye 1991; 5: 338-43. Department of Ophthalmology, postgraduate Institute of
4. Kampanartsanyakorn S, Surachatkumtonekul T, Medical Education and Research and Squint centre,
Dulayajinda D, Jumroendararasmee M, Tongsae S.The Chandigarh, India. 2006.01.182.
ABSTRACT
Aim:To measure the degree of esotropia postoperatively and determine the success of surgical outcome for congenital
esotropia managed in a tertiary care hospital.
Material and Method: A total of 53 patients were included in this Quasi Experimental Study carried out at the Department
of Ophthalmology, Jinnah Post Graduate Medical Centre, Karachi. The patients congenital esotropia underwent a bilateral
medial rectus recession by Parks cul-de-sac approach by researcher under supervision of consultant ophthalmologist
who has at least 5 years of clinical experience. Patients were re-evaluated by the researcher one week and then one
month post operatively. The results interpreted in the light of postoperative prism cover test measurements. Final outcome
was considered at the end of one month at which achievement of <10 PD of residual esotropia will be deemed as
success. Duration of study was 6 months.
Results :The age group of patients was between 1 and 27 years with a mean age of 7.98 yrs and a standard deviation of
6.72. The male patients were 35 in number and the female patients were 18. The maximum postoperative esotropia after
one month was 25 and the mean being 9.06 with a standard deviation of 5.806. Among the 53 patients 39 had a residual
esotropia of less than 10 PD and this constitutes for an overall success rate of 73.6% of the cases.
Conclusion:In conclusion, in eyes with congenital esotropia the surgical corrections proved that the results become
better after one month with a residual esotropia of 5 prism diopters which by definition is a successful outcome. The
surgical outcome of congenital esotropia in a tertiary care hospital had an overall success rate of 73.6% and an
undercorrection occurring for 26.4% of the patients.
Keywords: ,Esotropia, Rectus Muscle Recessions, Strabismus, Prism diopters
INTRODUCTION uses left eye in right gaze and right eye in left gaze.4
Congenital esotropia is one of the most common Other than strabismus, children with congenital
forms of strabismus 1 an ocular misalignment. esotropia are usually normal.5
Prevalence estimates of strabismus range from 1% to The goal of treatment in congenital esotropia is to
6% in different populations, with esotropia reported five reduce the deviation to orthophoria or as close as
times more frequently than exotropia in a country like possible.5 It is widely accepted that infantile esotropia
Ireland and twice as frequently in Australia. 2 It is associated with severe deficits of stereopsis and
represents more than half the ocular deviations in fusion. 6 The critical period of binocular visual
childhood.3 Congenital esotropia has been referred to development occurs around the first 4 to 6 months of
as infantile esotropia or essential esotropia.1Early onset life.7 The visual outcomes of patients with infantile
(congenital, essential, infantile) esotropia is an esotropia are substantially improved if the mis-
idiopathic condition developing within the first six alignment is corrected surgically early in life.9 Recent
months of life in an otherwise normal infant with no reports suggest that early muscle surgery is associated
significant refractive error and no limitations of ocular with greater prevalence of stereopsis and fusion.7-9
movements.4 Congenital esotropia never develops later Ideally, the eyes should be surgically aligned by the
than 6 months of age and more often develops at 2-3 age of 12months and at the latest by age of 2 year, but
months.1 only after ambylopia or significant refractive errors have
The misalignment is often readily apparent and been corrected. 4 The most common procedure is
the deviation is characteristically larger than 30 recession of both medial rectus muscles. The overall
diopters. 5 There is cross fixating in side gaze. The child success rate with one operation was 83.5 %.10
———————————————————————————————— There hardly exists any study pertaining to the
1,2,5
Postgraduates in Ophthalmology, 3Associate Professor, 4Medical success rate on the subject. of surgical outcome for
Officer, Jinnah Postgraduate Medical Centre, Karachi congenital esotropia. This study will help the result of
————————————————————————————————
Correspondence: Dr. Arif Rabbani, House 38/III, St. 32, Phase V bilateral medial rectus recessions in all patients coming
Extension. DHA, Karachi. E-mail: [email protected] for treatment.
Cell: 0300-2234128 MATERIALS AND METHODS
———————————————————————————————— This was a Quasi Experimental Study carried out
Received: Dec’2012 Accepted: Feb’2013
———————————————————————————————— at the Department of Ophthalmology, Jinnah Post
Graduate Medical Centre, Karachi for 6 months from of 5.806. Amongst 53 patients 39 had a residual
February 2011 to August 2011. 53 patients were esotropia of less than 10 PD and this constitutes for an
included in the study [Z = Level of confidence : 95% ,P overall success rate of 73.6% of the cases. 14 cases had a
= Prevalence of success rate : 83.5% (0.83), D = Margin residual esotropia of more than 10 PD which was 26%
of error: 10% (0.10) ]. (Non-probability purposive of the sample size and required a second stage surgery.
sampling technique was used). The graphs consist of a comparison between
The patients coming to the squint clinic of Jinnah preoperative degrees of esotropia and postoperative
Post Graduate Medical Centre were selected on the basis esotropia after one week as well as a comparison
of main complaints of ocular misalignment due to between degree of postoperative esotropia after one
congenital esotropia(present by the age of 6 months) of week and degree of postoperative esotropia after one
either gender, were included in the study, while patients month respectively.
with previous extraocular or intraocular surgery, central DISCUSSION
nervous system abnormalities, organic eye disease and Many studies have been conducted on surgical
esotropia due to other causes were excluded.The outcome on congenital esotropia. Several authors
informed written consent was taken from the subjects reported high rates of success, from 70 to 91%, in large-
for the surgical correction and they were enrolled in angle congenital esotropia with large medial rectus
the squint clinic for our study. All underwent a bilateral recessions, and no significant adduction limitations.11,12
medial rectus recession by Parks cul-de-sac approach Our study was conducted within a period of 6
by experienced ophthalmologist. Patients were re- months at Jinnah Postgraduate Medical Centre with a
evaluated by the researcher one week and then one sample size of 53 patients. A study was conducted by
month post operatively. The results were interpreted Dr Lihua Wang in China. It consisted of a sample size
in the light of postoperative prism cover test
measurement as explained earlier. Final outcome was Figure 1
considered at the end of one month at which
achievement of <10 PD of residual esotropiawas
deemed as success. This information was entered in the Success rate after surgery
performa attached. The database was analyzed on SPSS
version 12.0 on computer. The groups of success (PD
<10) and failure (PD > 10) was compared by Fisher’s
exact test or chi-square test. The age group of patients
were stratified to know the confounding effect of these
variables. The continuous variables such as age (in yrs)
and degree of esotropia (in PD) pre and post operatively
was presented as mean ±SD. The result were considered
significant with P < 0.05
RESULTS
53 patients were selected in the study,the age
group of patients were between 1 to 27 years, with a
mean age of 7.98 yrs and a standard deviation of 6.72.
The male patients were 35 in number and the female
patients were 18. The frequency of the male gender was
66% out of the 53 patients and 34% were females. On
assessment with prism cover test, the preoperative Figure 2
degree of esotropia ranged between a minimum of 30
and maximum 95 prism diopters. The prism cover tests
were done one week and one month postoperatively.
ESOTROPIS IN PD
The postoperative degree of esotropia after one week
was a minimum of 5 diopters to a maximum of 25 prism
diopters residual esotropia which has a mean of 9.72
and a standard deviation of 6.078. The results proved
to become better after one month where most of the
cases had a residual esotropia of 5 prism diopters. The
maximum postoperative esotropia after one month was
25 and the mean being 9.06 with a standard deviation
cases have unusual presentation and devastating visual 8/0 absorbable suture and corneal wounds with 10/0
results8. nylon. In case of sever corneal damage soft bandage
Ocular injury is more common in the rural contact lens was also applied after repair for one week.
residents where injury is usually related to agricultural Associated traumatic cataract was managed in
work. In city area eye injury occurs during travelling selected cases during primary repair and in others after
or at work places. In both these areas, eye injury is more 3-4 weeks. Intravitreal injection of vancomycin and
common in unskilled young persons. The commonest amikacin were given in case of endophthalmitis.
form of ocular insult is penetrating open globe injury. Patients with retinal detachment or intravitreal foreign
Younger age, male gender, addiction and lack of body were referred to vitreoretinal surgeon after
protective measures were the major risk factors for primary repair. Skin sutures were removed after 7 days
ocular trauma. The main purpose of this study was to and corneal sutures were removed after 6 to 8 weeks
identify the causes and type of eye injuries in rural and depending on the wound condition.
urban patients, to save sight with proper management, Visual acuity and slit lamp examination was done
and put forward suggestions to control risk factors on first post-operative day and on each follow up, on
which lead to ocular injuries. day seven, day fifteen, one month, two months and
PATIENTS AND METHODS: three months.
Independent randomly selected 104 patients DATA ANALYSIS
(simple random sample) of either sex from 3 to 60 years SPSS 14.0 (Statistical Package for Social Sciences)
of age having acute ocular injury were registered. The was used for statistical analysis. Paired t-test was used
sample size for 95% confidence interval and reliability to assess visual acuity in numbers of eyes before and
was calculated with formula N= (SD/SE)2 where N is after management of ocular injury in rural and urban
sample size, SD is standard deviation and SE is standard patients. For data analysis visual acuity was used in
error of the mean. Every patient with ocular injury was decimals. Mean visual acuity before management was
prospectively interviewed, examined, and admitted for 0.1 and after management was 0.4, independent sample
management. History about pattern of work and test was performed to see significant difference between
preventive measures taken during work, any history urban and rural patients. There was no significant
of alcohol, drug, and tobacco or gutka addiction was difference in visual outcome between urban and rural
also noted. patients, P-value 0.281. However there was significant
Inclusion criteria: Patients with ocular injury improvement in vision in both groups after
presented for the first time within 30 days of trauma management of ocular injury P-value 0.002. Mean
were included in the study. difference between presenting and final visual outcome
Exclusion criteria: Patients with history of after management was 0.3. Standard deviation 0.19 and
previous treatment elsewhere, old ocular trauma, and standard error mean 0.02.
with mild injury (corneal/conjunctival foreign bodies RESULTS
and abrasion) were not included in the study. Ocular Out of 104 registered patients 88 completed three
trauma with severe head injury was also excluded from months follow up. There were 66(75%) male and
the study. Verbal / written consent was taken from the 22(25%) female patients, with male to female ratio of
patients. In case of children counseling was done with 3:1. The mean age was 18.43 years, ranging from 03 to
the parents and consent obtained. The examination was 60 years. Rural patients were 50(56.8%) and urban 38
done starting with name, age, sex, gender, residency,
cause of ocular injury and duration. Table No. 1: Demographic Data of Patients
Visual acuity was taken and if possible anterior
and posterior segment examination was performed with Features No: of patients
slit lamp and 90D condensing lens. The intraocular Total patients 88
pressure was taken in co-operative patients with closed 15 years and less 51
glob injury. The site and extent of ocular trauma was Above 15 years 37
localized on slit lamp. Necessary investigations like B- Mean age (in years) 18.43
Scan ocular ultrasound and x-ray orbit was done in Range(in years) 3-60
selected cases, complete blood count, and blood glucose Male 66
levels were also performed. The photographic record Female 22
of all the subjects was maintained before and after Male to female ratio 3:1
surgical intervention. The surgical repair was carried Urban 38
out as early as possible. Lid laceration and periocular Rural 50
injuries were sutured with 6/0 vicryl, scleral cuts with Addicts 18
(43.18%). Demographic data is given in table 1. The most Table No: 4 Associated Findings of Ocular Trauma
common cause of ocular injury was wooden stick; these
patients were mainly from rural areas. The details of Open globe injury No. of Closed eye injuries No. of
causes are mentioned in table no: 2. n=47 Patients n=18 Patients
Commonest type (53.41%) was open globe injury Iris prolapse 19 Cataract 07
(penetrating, perforating, rupture). Patterns of ocular Cataract 17 Hyphema 05
injuries are shown in table No 3. Notable associated Hyphaema 15 Vit: hemorrhage 03
findings of closed and open globe injury were traumatic
Vit: hemorrhage 14 RD 01
cataract, hyphema, and optic nerve damage in some
patients. Only 11(20.45%) patients took preventive Endophthalmitis 07 Glaucoma 01
measures like wearing helmet during driving and Uveal prolapse 06 Iridodialysis 01
protective glasses during their work. Optic Nerve damage 02 Macular edema 02
Over all at initial presentation, mean visual acuity
was 0.1 (6/60) and final mean visual acuity after
Table No: 5 Visual Acuity Before and After Management n=88
management was 0.4 (6/18). Average vision improved
by three lines of Snellen’s chart.There was no significant No: of patients No of patients
difference in visual outcome between rural and urban V/A Before After P-Value
patients, P-value 0.281. Average visual outcome was management management
slightly better in urban patients by one line of snellen’s 6/6 04 10
6/9 to 6/18 06 26
chart.Visual acuity before and after management is 6/24 to 6/60 09 35 .002
given in table no: 5 CF 14 03
HM 18 01
Pl+ 24 02
Table No: 2 Causes of Ocular Trauma n=88- NPL 13 11
Note: Paired-ttest was used for visual acuity before and after
Source N/o eyes (%) under 15yrs above 15yrs management.
Stick 18 (20.45%) 10 08
RTA 12 (13.63%) 05 07
Pencil 08 (09.09%) 07 01
Stone 07 (07.95%) 03 04
Fall 06 (06.81%) 04 02
Glass 05 (05.68%) 02 03
Knife 05 (05.68%) 04 01
Sickle 05 (05.68%) 04 01
Fig. 1A: Penetrating trauma Fig. 1B: After repair
Fire cracker 05 (05.68%) 04 01 (Open globe)
Scissor 04 (04.54%) 03 01
Screw driver 03 (03.41%) 03 00
Finger nail 03 (03.41%) 02 01
Chisel iron piece 03 (03.41%) 00 03
Electric wire 02 (02.27%) 00 02
Fishing hook 01 (01.14%) 00 01
Gunshot 01 (01.14%) 00 01
Total 88 51 37
after trauma had periocular injury, where eye ball was areas of Pakistan do suffer from blast injuries to eye.
not affected. After Afghanistan and Russian war, eye injuries due to
DISCUSSION mine blast resulted in 37.37% blindness and 47.1% were
Trauma to the eyes is common in males of all ages left with visual impairment15.
but frequently occurs in younger and active age group Work related injuries also vary in different areas
including children. It causes great impact on vision and of Pakistan. In Khairpur and Turbat people receive
cosmetic appearance so patient shows much concern injuries from leaves of date palms mainly during
about it.In addition to being a public health problem, summer season when they take fruits. Most of the
blindness and severe visual impairment resulting from injuries of our patients are work related (agriculture/
the injuries have important socioeconomic implications. industries) or accidental. Penetrating ocular injuries
Because eye injuries affect young working persons, were more common in our study, comparable to one
therefore it will affect their earnings for the whole life study in Lahore16.
and rather than supporting will become a dependent Criminally negligent attitudes, lack of protective
person. Although ocular trauma is commonest cause devices and playing of children with artificial weapons
of mono ocular blindness9 even then affected persons rather than with toys can make new generation more
face difficulties in getting jobs. Equally important are aggressive which will increase the incidence of ocular
indirect costs resulting from loss of productivity, trauma. This attitude is more common in under-
hospitalstay10 and initial anxiety of patients and parents. developed countries. In one study in Ghana ocular
In case of visual disability the cost of rehabilitation and trauma in children result in blindness in 54.2% of cases.17
care are also tremendous. The causes of eye injuries are also related to
The average age at presentation with ocular physical and psychosocial development. Children of
trauma in our study was 18.43 years as compared to younger age like to imitate adult behavior without the
one study in neighboring country India which is awareness of possible risks. School-aged children who
28.21.years11. This may be due to involvement of our are more physically active tend to take more risks to
children in labor than in education. gain acceptance by their peers. Severity and type of
The commonest cause of visual loss in our study injury are prognostic factors of final vision. Involvement
was infection. Post-traumatic endophthalmitis is a of vital structures of eye ball in the anterior and
catastrophic complication of penetrating eye injury posterior segment can jeopardize visual outcome or can
which occurs mainly due to agricultural trauma, stones even lead to blindness. Optimum management of
and intraocular foreign bodies. In one of the study, trauma is related to improvement of visual recovery18.
infection occurred in 36(10.9%) patients12. In our study Ocular injury in our area is common in young
19.31% resulted in blindness in effected eyes (VA less unskilled persons or in those who do not take
than 6/60). Loss of vision in these patients was due to preventive measure during their work. In other
endophthalmitis or optic nerve/retinal injury. Most of countries eye injuries are common in persons who drink
these patients reached hospital after four days. alcohol19. Primary repair is possible in most of the cases
The annual rate of hospitalized eye injuries in with superficial damage with better visual outcome,
Australia is 25.5 per 100,000 population, 17% of these while the severely damaged eyes require enucleation,
are penetrating. Males between 20-24 have higher rates microsurgical secondary repairs or vitreoretinal
of hospitalization than females and interpersonal procedures20. In our study we have not done any
violence is the most common type of injury mechanism enucleation, severely damaged eyes were referred to
(27.4%). The home is also the most common specified vitreoretinal surgeon after primary repair.
location of the incident and eye injuries were identified Due to limited resources and lack of facilities at
as work-related in 9.8% of cases.13. In our region rural primary eye care level patients do not receive proper
women, working in agricultural lands receive ocular treatment well in time. Therefore patients from remote
injuries; therefore male to female ratio is 3:1 in this areas reach tertiary eye hospital late and many of them
region. ignore follow up which affects results of treatment and
Cause or mechanism of injury and male to female problem in data collection.
ratio of ocular injuries may vary in different Availability of treatment facilities at primary
countries.The most common cause of eye injury in rural health care centers and prevention of ocular injuries are
is by wooden stick which occurs during agricultural the mainstay of the management and various protective
labor. Agricultural trauma is also common in rural areas measures are advocated in the form of training, wearing
of neighboring country. In one of the studies it was protective clothes; protective eyewear20and keeping safe
46.9%.14 In our study one patient suffered from fire arm working distance.22
injury with loss of eye. However peoples of war affected CONCLUSION
ABSTRACT:
Purpose: To compare the safety, efficacy, and dosing regimen of intravitreal ranibizumab as an adjunct to laser therapy
for the treatment of macular edema secondary to branch retinal vein occlusion (BRVO).
Materials and Methods: Thirty eyes of 30 patients of BRVO of at least 6 weeks duration were randomized into three
groups: Group 1 received grid laser treatment alone, Group 2 received a single dose of intravitreal injection of ranibizumab
(0.5 mg / 0.05 ml) followed by grid laser treatment on 7th day following injection, while Group 3 received three loading
doses of intravitreal ranibizumab at monthly interval (i.e. 0, 1, & 2 months) + standard laser treatment 7 days after the 1 st
injection. Outcome measure noted at 6 months follow-up were the improvement in best corrected visual acuity (BCVA)
and central macular thickness (CMT).
Results: At 6 months follow-up, there was an average gain of 12 letters (P=0.05), 17.5 letters (P=0.05) and 19 letters
(P=0.05) in groups 1, 2, and 3, respectively, with the decrease in CMT being 208.7 μm (P=0.05), 312.9 μm (P= 0.05) and
326.8 μm (P=0.05) respectively, in these groups. Gain in BCVA of more than 3 lines was noted in 1/10 patients in Group
1(10%) as compared to 3/10 (30%) and 4/10 (40%) patients in groups 2 and 3 respectively.
Conclusion: The gain in BCVA and reduction in CMT were better with combination therapy (single and triple dose
regimen) compared to grid laser alone. Single dose of intravitreal ranibizumab with grid laser seems to be an effective
therapy.
Keywords: Branch retinal vein occlusion, laser, Lucentis, macular edema
Perfused BRVO was defined as lacking evidence of Table 1: Baseline characteristics of patients in three groups
neovascularization in the retina or iris, with no obvious
macular ischemia. The exclusion criteria were previous Group 1 Group 2 Group 3
treatment for BRVO, such as intravitreal injection, Duration of occlusion
subtenon injection, or laser photocoagulation, since the at entry into study (in
time of onset of BRVO, a history of glaucoma, macular months)
edema secondary to other causes, such as age-related 1.5 – 12 10 10 09
macular degeneration and diabetic retinopathy. >12 0 0 1
After obtaining an informed consent and Age (in years)
explaining the treatment outcomes, the patients were 40 – 49 2 1 3
randomized into three groups. The baseline 50 – 59 1 1 0
characteristics of the patients in three groups were >60 7 8 7
comparable as shown in Tab:1 Group 1 received Sex
standard grid laser treatment alone. Group 2 received M 6 5 6
a single intravitreal injection of ranibizumab (Lucentis; F 4 5 4
Genentech, San Francisco, CA, USA ) (0.5 mg / 0.05 Study eye
ml) on Day 0 followed by grid laser treatment on Day L 2 4 3
7, while Group 3 received three doses of intravitreal R 8 6 7
ranibizumab at monthly interval (i.e. 0, 1, and 2 months) Hypertension
with grid laser treatment on the 7th day following the Yes 7 6 7
first injection. At baseline, all the patients under- went No 3 4 3
a thorough ophthalmological examination, including Mean BCVA 0.158+0.01 0.18+0.04 0.144+0.02
best corrected visual acuity (BCVA) measurement with (in decimal system)
a Snellen chart and Early Treatment Diabetic Mean OCT thickness 500.2+141 493.2+140 515.7+126
Retinopathy (ETDRS) chart, applanation, tonometry, (in μm)
ophthalmoscopy, slit- lamp examination with 90D,
fluorescein angiography, and optical coherence Fisher’s exact test, as appropriate. The data were
tomography. analyzed via repeated measures analysis of variance
For grid laser therapy, the guidelines followed were: with a Bonferroni correction. The level of statistical
• Spot size: 50 - 100 ìm significance was set at 0.05 (two sided) in all statistical
• Exposure: 0.05 - 0.1 second tests.
• Burn intensity: Mild RESULTS:
• Number: As per areas of diffuse retinal thickening Visual acuity outcomes
• Placement: 1 - 2 burn-widths apart (500 - 3000 ìm In Group 1, mean BCVA improved from 0.158±
from center of fovea) 0.01 at baseline to 0.162±0.02 at 1 month, 0.192± 0.01 at
• Wavelength: Green 3 months, and 0.289 at 6 months, i.e., there was a BCVA
Eyes that were randomized into groups 2 and 3 improvement of 11± 3 letters at 1 month to 11.5± 5 letters
received intravitreal ranibizumab ( 0.5 mg/ 0.05 ml) at 3 months and 12± 5 letters at the end of 6 months
under sterile conditions. After the injection, a topical (P= 0.05). In Group 2, the response was rapid after the
antibiotic was applied and the patients were monitored intravitreal injection, with a mean BCVA improvement
for potential injection related complications. The main of 16± 4 letters at 1 month from baseline (from 0.18±
parameters evaluated were BCVA and CMT on OCT at 0.04 at baseline to 0.433± 0.02 at 1 month). After 3
1, 3, and 6 months after the initial injection. Fluorescein months, the mean BCVA improved by 17± 5 letters
angiography was performed at baseline and at each (0.439± 0.02), and at 6 months the gain increased to 17.5±
monthly visit for 6 months. Blood pressure was 5 letters (0.459± 0.02) (P= 0.05).In Group 3, there was
measured at baseline and at each monthly visit. an average gain of 15.8± 2 letters at the end of 1 month
Statistical analysis was performed using a (from 0.144± 0.02 at baseline to 0.306± 0.02 at 1 month),
commercially available statistical software package which increased to 17.7± 3 letters at the end of 3 months
(SPSS for Windows, version 16.0; SPSS, Chicago, IL, (0.338± 0.02) and was sustained at 18± 4 letters (0.432±
USA). Visual acuity was converted into the logarithm 0.02) at the end of 6 months (P= 0.05). Intergroup
of the minimum angle of resolution (logMAR) and comparison for BCVA at months 1, 3, and 6 was not
decimal system for statistical calculations. Univariate statically significant, but in Group 1, the mean
categorical analysis was performed using the two- improvement in BCVA of more than 3 lines was noted
paired t-test, Chi-square test, Mann Whitney U test, or in only 10% of the patients as compared to 40% in Group
2 and 30% in Group 3. A comparison of outcomes end of 6 months, Group 1 showed a decrease in CMT
between the three groups is depicted in Figure 1. of 208.7 μm as compared to 312.9 and 326.8 μm in groups
Imaging outcomes 2 and 3, respectively. The changes in the mean OCT
Paralleling the improvement in BCVA, thickness in the three groups have been illustrated in
ranibizumab treatment led to a rapid reduction in the Fig:2
(CMT). Similar responses were observed in single and DISCUSSION
triple dose regimens. In Group 1, center point thickness The natural history of macular edema secondary
decreased from a mean of 500.2± 141μm at baseline to to BRVO was delineated in the Branch Vein Occlusion
389.6± 120μm at 1 month, 334.6± 117μm at 3 months Study (BVOS).1 BVOS also demonstrated a benefit with
and 291.5± 109μm at 6 months (P= 0.05). In Group 2 grid photocoagulation in eyes with BRVO of 3-18
(single-dose regimen), there was a rapid decrease in months duration and visual acuity of 20/40 to 20/200.
mean CRT from 493.2± 140μm at baseline to 230.3± Treated eyes were more likely to gain 2 lines of visual
96μm at 1 month, 200.3± 92 μm at 3 months that further acuity (65%) compared with the untreated eyes (37%).
decreased to 180.3± 78 μm at 6 months (P= 0.05). In Furthermore, treated eyes were more likely to have 20/
Group 3, (triple dose regimen) mean CMT decreased 40 or better vision at 3 years follow-up (60% vs. 34%
from 515.7± 126 μm at baseline to 386.2± 97 μm at 1 untreated), with a mean visual acuity improvement of
month, 286.4± 87 μm at 3 months, and was sustained at 1.3 lines ETDRS versus 0.2 lines in the untreated group.
188.9± 76 μm at 6 months (P= 0.05). Though intergroup The rationale for the use of anti VEGF to treat
comparison results were not statically significant, at the macular edema secondary to BRVO follows from the
Figure 1: Comparison of visual outcomes between Group 1
observation that the increase in retinal capillary
(laser alone), Group 2 (single loading dose with laser), and Group permeability that results in macular edema may be
3 (triple loading dose with laser) over a period of 6 month caused by a breakdown of the blood retina barrier,
mediated in part by VEGF,3 a 45-kDa glycoprotein.
Therefore, attenuation of the effects of VEGF may
reduce macular edema associated with BRVO. Anti
VEGF has been demonstrated to bind and neutralize
all the biologically active forms of VEGF, and therefore
may be an effective therapy for macular edema.
The BRAVO trial (a phase 3, multicenter,
randomized, sham injection-controlled study of the
efficacy and safety of ranibizumab injection compared
with sham in patients with macular edema secondary
to BRVO) assessed the safety and efficacy of
ranibizumab in patients with BRVO.3 Patients included
in the study had macular edema involving the foveal
center secondary to BRVO, central subfield macular
thickness of 250 μm or greater on OCT, and BCVA of
Figure 2: Changes in the mean OCT thickness in the
20/40 to 20/400. Patients were randomly assigned to
three groups over 6 months following treatment six monthly injections of ranibizumab, either 0.3 mg or
0.5 mg, or to sham injection. In 397 patients randomized,
the mean gain from baseline at month 6 was 16.6 letters
in patients receiving 0.3 mg of ranibizumab, 18.3 letters
in those receiving 0.5 mg, and 7.3 in those receiving
sham injections. By month 6, most patients in the two
ranibizumab groups gained at least 3 lines of BCVA
(55.2% in the 0.3 mg group and 61.1% in the 0.5 mg
group), while most of those in the sham group did not
(28.8%). This trial, however, enrolled all comers,
irrespective of the duration of their disease.
We believe that as the disease was seen to resolve
spontaneously in one-third of the patients in the BVOS
study, treatment can be delayed for at least 6 weeks to
permit maximum resorption of intra-retinal blood and
edema. In this small, randomized, controlled study,
intravitreal ranibizumab at 4 weeks interval along with difference for a gain in BCVA was noted in the three
grid laser provided rapid and sustained improvement treatment groups, the fact that gain in BCVA of more
of BCVA in subjects with BRVO for 6 months period. than 3 lines was noted in 40% patients of combination
40% of the subjects gained at least 3 lines of vision in 24 therapy compared to 10% patient in standard laser
weeks. The rapid improvement in vision was paralleled group helped us conclude that ranibizumab may be
by reductions in macular thickness. Almost similar used as an effective and safe adjunct to laser in the
improvements were observed in the single and the triple treatment of macular edema secondary to BRVO. Since
dose groups. economics plays a major role in treatment involving
It is our belief that the endpoint gain in BCVA anti-VEGF administration, this alternative treatment
would be greater if an anti-VEGF is used prior to laser modality may prove to be a viable option in the
therapy. Anti-VEGF would decrease the macular developing countries.
thickness, allowing effective laser uptake at a lower Limitation of this study includes the small study
power. The results in Groups 2 and 3 of our study population. Despite this limitation, the results of this
illustrate this point (as 70% of the treated eyes gained study suggest that intravitreal ranibizumab is an
and maintained 2 or more lines of BCVA from baseline). effective option for the treatment of BRVO and that
In BRAVO study, after six doses of intravitreal larger, more definitive, randomized clinical trial are
ranibizumab at the end of 6 months, there was a gain warranted to determine the optimal treatment interval
of 16.6 letters and 18.3 letters and the mean changes in and duration.
CMT were 337.2 and 345.2 μm in 0.3 and 0.5 mg groups, REFERENCES:
respectively. Although a direct comparison cannot be 1. The Branch Vein Occlusion Study Group. Argon Laser
photocoagulation for macular edema in Branch vein
made because of difference in the study design, it is occlusion. Am J Ophthalmol 1984;98:271-82.
worth while noting that in our study the mean 2. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle
improvement in BCVA was 17.5 letters in Group 2 and CA, et al.; BRAVO investigators. Ranibizumab for Macular
18 letters in Group 3 at the end of 6 months. Similarly, Oedema following BRVO: Six month primary end point
results of a phase 3 study. Ophthalmology 2010;117:1102-12.
a decrease in CRT of 312.9 and 326.8 ìm in groups 2 3. Campochiaro PA, Hafiz G, Shah SM, Vguyen QD, Ying H,
and 3, respectively was noted. Do DV, et al. Ranibizumab for macular oedema due to retinal
CONCLUSION: vein occlusions; implications of VEGF as a critical stimulator.
In our study design, though no significant Mol Ther 2008;16:791-9.
This 18-year-old patient had a postural tremor of her arms and legs, mild dysphagia
and dysarthria, and bradykinesia. Measurement of urinary copper and ceruloplasmin
confirmed the diagnosis of Wilson’s disease. The rings resolved following chelation
therapy.
An 18-year-old woman presented with color and temperature changes in her hands,
as well as intermittent tremor of the hands since the age of 15 years. She also reported
involuntary right arm movements and difficulties with concentration. Physical examination
of the eyes revealed bilateral Kayser–Fleischer rings. Neurologic examination revealed
dystonia of the right arm, a postural tremor of her arms and legs, mild dysphagia and
dysarthria, and bradykinesia. Laboratory tests revealed elevated serum levels of alanine aminotransferase, aspartate
aminotransferase, and γ-glutamyltransferase, as well as low serum levels of ceruloplasmin (0.02 g per liter; reference
range, 0.2 to 0.5) and copper (4.1 μmol per liter; reference range, 11 to 22); the urinary copper excretion was elevated, at
12.8 μmol per 24 hours (reference range, 0 to 1). Magnetic resonance imaging of the patient’s brain revealed widespread
signal change, gliosis, and atrophy in the basal ganglia, thalami, and brain stem. A diagnosis of Wilson’s disease was
made and confirmed on genetic testing by a result of a compound heterozygous mutation in the gene ATP7B. Approximately
5 years after the initiation of copper-chelating treatment, the Kayser–Fleischer rings had resolved almost completely, and
there was stabilization in neurologic status and MRI findings.
(Curtesy: NEJM-UK.)
ABSTRACT
Purpose: To compare the safety and efficacy of subtenon anaesthesia with peribulbar anaesthesia in manual small
incision cataract surgery using a randomised control clinical trial.
Material & Method:Ninety patients were randomized to subtenon and peribulbar groups with preset criteria after informed
consent. All surgeries were performed by a single surgeon. Pain during administration of anaesthesia, during surgery and
4 hour after surgery was graded on a visual analogue pain scale and compared for both the techniques. Sub-conjuntival
haemorrhage, chemosis, akinesia after administration of anaesthesia and positive pressure during surgery were also
compared. Patients were followed up for 6 weeks postoperatively.
Results: About 78/90(86.66%) patients completed the six-week follow-up.Fifteen out of 45(33.33%) patients of peribulbar
group and thirty four out of 45(75.55%) patients of subtenon group experienced no pain during administration of anaesthesia.
There was no significant difference in pain during and 4 hour after surgery. Subtenon group had slightly more sub-
conjunctival haemorrhage. About 32(71.11%) patients of the peribulbar group had absolute akinesia during surgery as
compared to none (0%) in sub-tenon group. There was no difference in intraoperative and postoperative complications
and final visual acuity.
Conclusion: Sub-tenon anaesthesia is safe and as effective as peribulbar anaesthesia and is more comfortable to the
patient at the time of administration.
Keywords: manual small incision cataract surgery; peribulbar anaesthesia; sub-tenon anaesthesia
2. Sensitivity to Xylocaine using a 24G needle at junction of middle and outer third
3. History of convulsion, epilepsy of the lower orbital margin with the needle directed
4. Inability to give informed consent towards floor of orbit. A supplementary injection of 1
5. People who preferred phacoemulcification ml was given at the supra orbital notch. The eyelid was
or conventional extracapsular surgery then closed and pressure was applied for 5 min.Visual
6. Previous intraocular injury, inflammation or analog pain scale used tograde the pain they felt on a
surgery linear scale of 0-4
7. Pupil <5 mm in diameter No pain = grade 0,
8. Inability to understand the visual analogue Mild pain= grade 1,
pain scale. Moderate pain =grade 2,
Assuming 90% power and 5% level of significance Severe pain = grade 3 and
and assuming that there would be no pain in 40% and Maximum pain imaginable = grade 4.
60% of cases by either technique (difference of Patients were asked to grade separately for pain
proportions), each arm should have a minimum of 31 during administration of anaesthesia, pain during
patients. Assuming loss of 20% to follow-up, the study surgery and pain 4 h after surgery. The last was taken
aimed to randomize at least 77 patients. Permission was when the patient was shifted to the wards. The
obtained from the ethical committee of the hospital. ophthalmologists also graded for chemosis,
Both techniques of anaesthesia are acceptable standards subconjunctival haemorrhage after administration of
of care and have been in use for more than a decade. anaesthesia and positive pressure during surgery on a
The consent form and information sheets for the patients scale of 0-4, of increasing severity. ‘Akinesia’ was scored
were designed as per the Helsinki protocol guide lines on a scale designed to measure ocular movements in
and translated into urdu. Informed consent was each quadrant (no movement = score 0, mild = 1,
obtained from all the patients who participated. Each moderate = 2, severe = 3 in each quadrant, minimum
patient was randomly assigned by opening an envelope score possible = 0, maximum score possible = 3 x 4 =
on entering the recovery (pre-anaesthetic) room. The 12). The surgeon also graded for the ‘discomfort’ he felt
peribulbar anaesthesia was administered by the during surgery (grade 0 = no discomfort, grade 1 = mild
anaesthetist and the subtenon anaesthesia was given discomfort, grade 2 = moderate, grade 3 = severe, grade
by the surgeon on table. Any extra anaesthetic needed 4 = surgery not possible).
was noted. The patients and the surgeon were masked RESULTS
till 10 min before surgery. The patient was asked to About 78/90(86.66%) patients completed the six-
gauge for the pain during administration of the week follow-up. About 90 patients underwent MSICS
anaesthetic, pain during surgery and after it was between July 2010 to June 2011 and were operated upon
completed. Postoperative pain after 4 h was also by a single surgeon.25/45(55.55%) were males, in
recorded. After each surgery the surgeon was asked to peribulbar group and 27/45(60.00%) in the subtenon
score for akinesia and to grade for positive pressure group. Average age in the two groups was 58 and 56
during surgery, chemosis, subconjunctival years, respectively. There was no statistically significant
haemorrhage and overall discomfort. Intraoperative difference between the two groups with respect to age
complications were noted. All patients underwent ( p = 0.133) and sex. ( p = 0.213).The various grades of
MSICS; any change in technique, if needed, was pains during anaesthesia are depicted in Table -1. Chi
noted.The patients were followed on the first square test shows that there is a significant difference
postoperative day, first week and sixth week after between both the groups with regards to pain on
surgery. The postoperative complications were noted, administration of the anaesthesia for grades 0 and 1
as also the best corrected postoperative visual acuity (p< 0.0001). p = 0.09 for grade 2, p = 2 for grade 3 by
and refraction.The eye to be operated was painted with figure exact test, there being no statistically significant
povidone iodine. After draping, a lid speculum was difference for grade 2 or more. The average for pain
applied and two drops of topical 4% lignocaine were during anaesthesia was grade 0.82 for the peribulbar
instilled. group and 0.26 for subtenon group on a range of 0-4.
Conjunctival forceps were used to grip the Table - 2 shows the various grades of pain during
conjunctiva and a curved subtenon cannula was then surgery in both the groups. Average for pain during
inserted on to bare sclera and glided along the contour surgery was 0.15 for peribulbar and 0.07 for subtenon
of the globe. One ml of 2% lignocaine with 1:10 000 on a range 0-4. Table -3 describes the various scores of
adrenaline was injected slowly in the posterior subtenon ocular movement after anaesthesia. 43 out of 45(95.5%)
space.Technique of peribulbar anaesthesia was, four ml of patients in peribulbar group had scores of 4 or less;
of 2% lignocaine with 1:10 000 adrenaline was injected 41/45(91.1%) of patients of subtenon group scores of 6
or more, with the mode score of 10. The mode for Table 3: Ocular movements during surgery
peribulbar group was 0. This was statistically very
Akinesia(score) Peribulbar: Subtenon: Total
significant ( p< 0.0001). Average score for akinesia was
95% CI 95% CI
1.2 in peribulbar group and 8.4 in subtenon group on a
range0-12.About 45/45 (100%) patients of peribulbar 0 29(64.4%) 0 29(32.2%)
group and 44/45(97.7%) patients of subtenon group did 2 7(15.5%) 0 7(7.7%)
not have any positive pressure during surgery. Only 4 7(15.5%) 5(11.1%) 12(13.3%)
one patient of subtenon group had minimal pressure 6 1(2.2%) 4(8.8%) 5(5.5%)
rise.Various grades of subconjunctival haemorrhage in 8 1(2.2%) 17(37.7%) 18(20.0%)
both the groups is described in Table - 4 whereas
10 0 18(40.0%) 18(20.0%)
Table - 5 describes various grades of conjunctival
chemosis in both the groups. In 43/45(95.5%) surgeries 12 0 1(2.2% 1(1.1%)
under peribulbar anaesthesia and in 39/45(86.6%) Total 45(100%) 45(100%) 90(100%)
surgeries under subtenon anaesthesia, the surgeons
experienced no discomfort. All patients of the Table 4: Subconjunctival heamorrhage after
peribulbar group (45/45) reported no pain for 4 hours administration of anesthesia
after surgery compared to (44/45) patients in the Subconjunctival Peribulbar Subtenon Total
subtenon group. There were two posterior capsular
heamorrhage
rents in the peribulbar group. One patient in the
Grade0 27 18 45
subtenon group had button holing during scleral tunnel
creation. The incidence of postoperative complication Grade1 11 21 32
in both arms was similar. There was no significant Grade2 6 6 12
difference in both the groups with regards to Grade3 1 0 1
uncorrected and corrected visual acuity after 6 weeks Grade4 0 0 0
postoperatively. 42/45(93.3%) of patients in peribulbar
Total 45 45 90
group and 41/45(91.1%) in subtenon group had
postoperative corrected visual acuity >6/9. No patient
had visual acuity less than 6/60. One patient in the Table 5: Chemosis after administration of anesthesia
peribulbar group needed additional anaesthesia of 3cm3
Chemosis Peribulbar Subtenon Total
Grade0 29 28 57
Table 1: Pain during anesthesia
Grade1 9 13 22
Peribulbar: Subtenon: Total Grade2 6 4 10
95% CI 95% CI Grade3 1 0 1
Grade0(no pain) 16 (35.5%) 32 (71.1%) 48(53.3%) Grade4 0 0 0
Grade1(mild pain) 23 (51.4%) 10 (22.2%) 33( 36.6%) Total 45 45 90
Grade2(moderate) 4 (8.8%) 2(4.4%) 6 (6.6%)
Grade3(severe) 1 (2.2%) 1(2.2%) 2 (2.2%) of 2% xylocaine. One MSICS in subtenon group was
Grade4(max imaginable) 1 (2.2%) (0) 1 (1.1%) converted to ECCE due to difficulty in delivering the
Total 45(100%) 45(100%) 90 (100%) nucleus.
CI: Confidence Interval DISCUSSION
Subtenon anaesthesia was more comfortable for
Table 2: Pain during surgery the patient at the time of anaesthetic administration.
They also had good analgesia intraoperatively, but the
Peribulbar: Subtenon: Total
surgeons had to operate with incomplete akinesia,
95% CI 95% CI
which some may find discomforting. The incidence of
Grade0(no pain) 39(86.6%) 40(88.8%) 79(87.7%)
subconjunctival haemorrhage was also slightly more as
Grade1 (mild pain) 4(8.8%) 45(11.1%) 9(16.6%) compared to the peribulbar group. The surgery was
Grade2 (moderate) 0 0 0 started immediately after administration of anaesthesia
Grade3 (severe) 2(4.4%) 0 2(2.2%) in subtenon group. As lesser amount of the anaesthetic
Grade4 (max imaginable) 0 0 0 agent was used for subtenon, the chances of adverse
effects are also minimized. In a large hospital or in a
Total 45(100%) 45(100%) 90(100%)
CI: Confidence Interval
community eye care setting, the cost would also be less.
There was no difference in chemosis, positive pressure anaesthesia during MSICS is as safe as the peribulbar
rise during surgery and postoperative pain between technique giving equally good analgesia during and
both the techniques of anaesthesia. An audit of subtenon after the surgery. It is recommended as a safe and
and peribulbar anesthesia for cataract surgery in UK effective alternative to peribulbar anaesthesia for
demonstrated sub-Tenon’s methods to be more effective MSICS.
than the peribulbar technique, with significantly fewer REFERENCES
patients experiencing unacceptable levels of pain.10 It 1. Minasian DC, Mehera V. 3.8 Million blinded by cataract each
year: Projections of the first epidemiological study of
was significantly less uncomfortable on administration incidence of cataract blindness in India. Br J Ophthalmol
than the peribulbar methods and reduced the interval 1990;74:341-3.
between administration of anaesthesia and surgery. On 2. Marseille E. Cost-effectiveness of cataract surgery in a public
the range of 1-10, pain on administration of anaesthetic health eye care program in Nepal. World Health Organ Bull
OMS 1996;74:319-24.
had a mean of 2.4 for the peribulbar group and 1.4 for 3. Davis DB, Mandel MR. Efficacy and complication rate of
the subtenon group. This correlated with results of our 16,224 causative peribulbar blocks. A postoperative multi
study. The subtenon technique appeared to be the safest Centre study. J Cataract Refract surg 1994;20:327-37.
method of introducing anaesthetic fluid into the 4. Mount AM, Seward HC. Sceral perforations during
peribulbar anesthesia. Eye 1993;7:766-7.
retrobulbar space without the potential complication 5. Murdoch IE. Peribulbar versus retro bulbar anesthesia. Eye
of a sharp needle injection.13 But a single case of globe 1990;4:445-9.
perforation was reported 14 in a patient who had 6. Stevens JD. A new local anesthetics techniques for cataract
underwent detachment surgery and had thinned extraction by one quadrant sub-Tenon’s infiltration. Br J
Ophthalmol 1992;76:670-4.
sclera.It is likely that subtenons anaesthesia offers a 7. de la Marnieere E, Maye R, Albertim, Batissc JL, Baltenneck.
significantly reduced risk of complication such as scleral Comparison between Greenbachs Parabulbar Anaesthesia
perforation, retro bulbar haemorrhage, optic nerve and Ripart’s subtenon anaesthesia in the anterior. segment
injury and injection of anaesthetic solution into the surgery. J Fr Ophthalmol 2002;25:161-5.
8. Hansen EA, Mein CE, Mazzoli R. Ocular anesthesia for
subarachnoid space, as no sharp instrument is passed cataract surgery: a direct sub-Tenons’s approach. Ophthalmic
into the orbit. It should, however, be used with caution Surg 1990; 21 :696-9.
in patients with compromised sclera. A randomised 9. Gogate PM, Deshpande M, Wormald RP. Is manual small
study in Denmark comparing retrobulbar, subtenon incision cataract surgery affordable to developing countries?
A cost comparison with extra capsular cataract extraction.
and topical anaesthesia for phacoemulcification found Br J Ophthalmol 2003;87:843-6.
retrobulbar techniques had less discomfort/pain during 10. Briggs MC, Back SA, Esakowitz L. Subtenons versus
surgery but patient preferred subtenon or topical peribulbar anesthesia for cataract . Eye 1997; 11 :611-43.
anaesthesia, as it did not involve the needle prick during 11. Davis DB, Mandel MR. Nileson PJ Alerod CW. Evaluation
of local anesthesia technique for small incision cataract
anaesthesia.11 Subtenon anaesthesia has also been used surgery. J Cataract Refract Surg 1998;24:1136-44.
for optic nerve sheath fenestration. 15 Subtenon 12. Gogate PM, Deshpande M, Wormald RP, Deshpande RD,
anaesthesia has been found to be more comfortable for Kulkarni SK. Extra capsular cataract surgery compared with
the patient, reliable, long lasting and with deeper manual small incision cataract surgery in community eye care
setting in western India: a randomized control trial. Br J
anaesthesia as compared to topical anaesthesia for Ophthalmol 2003;87:667-72.
phacoemulcification patients. It was also more 13. Loinder S, Walka SB, Atth HR. Ultrasonic localization of
comfortable for the surgeon with better pupillary anesthetic fluid in subtenon, peribulbar and retro bulbar
dilatation.16 A randomised trial in the UK17 found the techniques. J Cataract Refract Surg 1949;25:56.
14. Freiman BJ. Friedberg MA. Globe Perforation associated with
difference between the pain score in the subtenon and sub tenon’s anesthesia. Am J Ophthalmol 2001;131 : 520-1.
topical groups to be highly statistically significant, with 15. Rizzuto PR, Spoor TC, Ramock JM, McHenry JG. Subtenon’s
subtenon being more pain free, for phacoemulcification local anesthesia for optic nerve sheath fenestration. Am J
patients.Limitations of the study include subjective Ophthalmol 1996;121:326-7.
16. Vielpeau I, Billotte L, Kreidie J, Lecoq P. Comparative study
nature of the visual analog pain scales and that the field of topical anesthesia and subtenon anesthesia for cataract
testing or optic nerve damage analysis was not done. surgery. J Fr Ophthalmol 1999;22:48-51.
But past studies and postoperative visual acuity results 17. Manner TB, Burton RL. Randomized trial of topical versus
indicate that it would not be significant. subtenon local anesthesia for small incision cataract surgery.
Eye 1997;10:367-20.
CONCLUSION
The subtenon’s technique for administration of
Primary posterior capsulotomy and anterior vitrectomy of managing after pediatric cataract. A significant
was done in all eyes. In children with bilateral lens (p<0.05) improvement in visual acuity was observed
opacities requiring surgery and the eyes with poorer after cataract surgery. Most frequent cause of decrease
vision was operated first and surgery for second eye vision after cataract surgery was amblyopia, which was
was performed three weeks later. All cases remained managed by occlusion therapy. A significant (p<0.05)
on topical steroids eye drops for six weeks. Patients improvement in visual acuity was observed after
were followed one day and one week for early occlusion therapy. We also tried to find out the possible
postoperative complications. Patients were also causes of cataract development among children, and
followed after 1 month and 2 months. Visual acuity was we observed that congenital cataract was the most
checked on the follow up after 1 month,especially those common type of cataract followed by traumatic cataract.
patients who had started on amblyopia therapy.All Amblyopia a common cause of decreased vision
those patients undergoing therapy were followed every in children after unilateral cataract and has been
two weeks.Final outcome was considered after 3 reported in many studies.8-10 In our study we also
months of therapy. Visual acuity was compared with
Table1: Multiple Associated Features along with Cataract
the visual acuity before amblyopia therapy (occlusion
of the good eye). Visual acuity was evaluated using Associated Features Frequency
the Teller Acuity Cards Test or the Lea Test depending Nystagmus 30
on the age and with one eye occluded. All refraction Microphthalmos 10
readings were taken after instillation of cyclopentolate Corneal Opacity 16
1%. Retinal Pathology 2
Data analysis was done using SPSS version 19. Subluxated Lens 20
Frequencies of gender, age, and complications were Ruptured Lens Capsule 8
recorded. Statistical analysis of the frequency of several Corneal tear 2
postoperative complications was performed by the Corneal edema 2
Fisher exact test. All tests were two-tailed, and Micro Cornea 4
acceptable significance was recorded when P values Esotropia 6
were less than 0.05. Paired t test will be used to compare
the visual acuity before and after amblyopic therapy. Figure1 Pre-Treatment (Baseline) and Post Surgery Visual Acuity
RESULTS Distribution
A total number of 410 patients were included in n = 410p-value <0.05
the study. Minimum age of the patient included in the
study was 2 months while the maximum age was 10
years, with mean age of 67.23 (standard deviation=56.4).
Out of 410 patients, 251 (61.2%) were male while 159
(38.8%) were female.Different types of cataracts were
observed during the study, congenital cataract was the
most frequent among all the other types of cataracts
seen. Multiple associated features were also observed
along with cataract in the patients, most common of
these were nystagmus, which was seen in 30 patients.
Others common associated features and their
VA= visual acuity
frequencies are shown in table-1. Right eye was HM=hand movement
involved in 211 patients, while left eye was involved in FC=finger counting
199 patients.The comparison of pre-surgical and post- Pl=perception of light
surgical visual acuity is in (Fig. 1).Amblyopia was the
Table 2:
most frequent cause of decreased vision among the Causes of Decreased Vision Post Operatively (VA < 6/18)
patients with best corrected visual acuity less than 6/
18, other causes (table 2). Amblyopia was seen in 214 Causes Frequencies
(52.2%) of patients. Best corrected visual acuity before Amblyopia 214
and after amblyopic therapy (Fig. 2). 148 (69.15%) Uveitis 2
patients out of 214 patients who were given amblyopic Retinal scar 5
therapy showed improvement in visual acuity (Fig. 3). Corneal opacities 6
DISCUSSION Others 2
In this study, we have tried to share our experience Total 210
Figure 2: Pre-Treatment (Amblyopia Therapy) and Post the fellow eye 2-4 hours/day), children between 4- 6
Treatment Best Corrected Visual Acuity Distribution months of age (patching the fellow eye 4-6 hours/day),
n = 214p-value<0.05
children older than 6 months (patching 50% of the day).8
As all the patients in our study were older than 6 months
we guided them to do the patching for 50% of the day.
Outcome of therapy was largely dependent on the
compliance of the therapy.We assessed compliance on
the basis of information given by the parents. If child
underwent occlusion therapy daily and almost fully as
desired it was rated as excellent, while if the child
underwent occlusion daily but not up to the hours
desired it was rated as good to fair. But if child skipped
days between the therapies it was rated as poor
compliance. We noted that highest number of children
who were rated as excellent in compliance showed
Figure 3: Improvement in Visual Acuity after Amblyopia Therapy improvement in visual acuity. On the other hand
children rated with poor compliance showed negligible
improvement in the visual acuity.Further research will
be required to investigate the ideal timing in pediatric
cataract surgery and hence prevention in the
development of amblyopia.
CONCLUSION
Congenital cataract is the most common type of
cataract seen in children, and it is along with other type
of cataracts can be successfully managed by performing
surgery , resulting in good visual improvement and
prevention in amblyopia.
REFRENCES
1. Wilson ME, Pandey SK, Thakur J.Paediatric cataract
blindness in the developing world: Surgical technique and
intraocular lenses in new millenium. Br J Opthalmol2003; 87:
noticed that the most frequent cause of decreased vision 14-19.
2. Lambort SP. Management of monocular congenital cataract.
postoperatively. It might be defined as interference of Eye 1999; 13: 474-79.
visual acuity development caused by short of stimuli 3. Angra, Mohan SK. Management of Rubella cataract. Ind J
or insufficient stimuli during critical periods of Ophthalmol 1982; 302: 13-16.
development. It can be classified as strabismic, 4. Lundvall A, Kugelberg U. Outcome after treatment of
congenital bilateral cataract. ActaOphthalmolScand 2002;
anisometropic or sensory deprivationdue to congenital 80:593–597.
cataracts. The treatment of infantile cataract is based 5. Robb RM, Petersen RA. Outcome of treatment for bilateral
on two major approaches: surgical removal of the congenital cataracts. Ophthalmic Surg 1992;23:650 –656.
opacified lens and optical therapy. Optical therapy or 6. Keech RV, Tongue AC, Scott WE. Complications after surgery
for congenital and infantile cataracts. Am J Ophthalmol
rehabilitation can be achieved with intraocular lens 1989;108:136 –141.
(IOL) implantation plus optical correction or optical 7. Lundvall A, Zetterström C. Complications after early surgery
correction without IOL implant.11 There are many ways for congenital cataracts. ActaOphthalmolScand 1999;77: 677–
of treating after sensory deprivation which includes first 680.
8. Ejzenbaum F,Salomão S.R, Berezovsky A, et al.After
removing the cause of sensory deprivation, afterwards, unilateral infantile cataract extraction after six weeks of age.
either occlusion therapy or penalization could be Arq Bras Oftalmol. 2009;72(5):645-9
performed. In our study we used the method of 9. Tanna AP, Abraham C, Lai J, et al.Impact of cataract on the
occlusion. We gave training to the parents for one week results of frequency-doubling technology perimetry.
Ophthalmology2004;111:1504–7
when they started occlusion therapy along with the 10. Desai P,Reidy A, Minassian DC.Profile of patients presenting
counseling regarding the importance of this therapy. for cataract surgery in the UK: National data collection. Br J
As a result 69% of the children had improvement of a Ophthalmol1999;83:893–96
single line or more after they underwent this occlusion 11. Hassan M, Qidwai U. Complication and Visual Outcome after
Peadiatric Cataract Surgery with or Without Intra Ocular
therapy. Patching therapy was prescribed after optical Lens Implantation, Pak J Ophthalmol 2011, Vol. 27 No. 1
correction our study used the following scheme of
patching children between 2-4 months of age (patching
attention was paid towards lid examination, pupillary brain was normal in all the cases. None of the patients
reflexes, and extraocular movements. had isolated weakness of extraocular muscles
Ptosis, if present, was graded. Pupils were checked innervated by only the superior or inferior division of
for size, shape, and light reflexes. Pupillary involvement the oculomotor nerve.
was scrutinized by measuring the pupil size and its Among the other risk factors associated with the
reactivity to light. Standardized methods were used to development of vasculopathic oculomotor nerve palsy,
measure pupil size. Patients were instructed to look at hypertension was seen most frequently (42.8%),
a target kept 6 meters away under stable room light followed by hypercholesterolemia (40%), smoking
conditions. A pupil gauge accurate to within 0.5 mm (28.57%), coronary artery disease (14.2%) and
was used to measure the pupil diameters. The patients alcoholism (11.3%).
were engaged in conversation to ensure that they were 9 patients (25.7%) were found to have an internal
alert. The degree of anisocoria, if present, was recorded. ophthalmoplegia along with external ophthalmoplegia.
Anisocoria, if present, was again measured under The mean age in this group was 57.56 ± 11.98 years
dim light conditions to rule out simple (physiological) (ranging from 40 to 78 years), and mean duration of
anisocoria. An anisocoria was termed as simple if it diabetes was 7.27 ± 5.7 years. Patients presented to us
remained similar in room light as well as in dim light. on an average 9.1 ± 6.5 days after the onset of symptoms.
The quality of direct pupillary light reaction was also Some degree of anisocoria (pathological and simple
recorded. anisocoria) was measured in 31.1% of the patients at
Hess charting and diplopia charting were done presentation. Based on pupillary findings at the final
in all cases to confirm oculomotor nerve palsy. visit, 4 kinds of patterns could be identified in all
Standardized method to quantify the degree of subjects
ophthalmoplegia by recording the relative limitation of In 9 patients, the measure of anisocoria ranged
ocular ductions of the superior, inferior, medial recti from 1 mm to 2 mm (median size 1.5 mm) with the
muscles and inferior oblique using a 0 to 4 scale was frequency distributed equally between 1, 1.5, and 2 mm
used.9 0 represented full duction; 4 complete absence of anisocoria (33.3%). None of these patients had a fully-
of function; and 1, 2 and 3, 25%, 50% and 75 % dilated, non-reactive pupil.
impairment of duction, respectively. A single Figure 1 represents the course of anisocoria at
ophthalmoplegia grade was determined by calculating each visit for each of the 9 patients (A - I) who had
the arithmetic mean of the relative limitation of ocular pupillary involvement. In patients with incomplete
ductions of the involved 4 muscles. resolution, residual anisocoria was <1 mm. The direct
Patients were subjected to a fundus examination pupillary reaction was impaired variably in all subjects
with a 78 D lens to document any signs of diabetic during the 1st 2 visits, but the reaction normalized or
retinopathy. MRI of brain were done in all cases to rule near normalized as ophthalmoplegia resolved. Patient
out surgical lesions. Blood pressure measurement, ‘C’ and ‘E’ were lost to follow-up at 2nd and 3rd visit,
random blood sugar, erythrocyte sedimentation rate respectively.
and serum cholesterol were recorded in all cases. They Comparison of anisocoria at different visits (Post
were treated with oral methylcobalamin.10 They were Hoc tests) revealed that there was a significant
advised to control diabetes and other associated difference in the degree of anisocoria between the
systemic disorders and to undergo ocular 1st and 3rd visits (P = 0.02) and the 2nd and 3rd visits
physiotherapy. They were reviewed again after 2 weeks (P = 0.02). In most of the patients with pupillary
and 8 weeks from the baseline visit. Lid position, extra- involvement, the maximum anisocoria developed
ocular movements, pupil size, and reaction to light were within the 1st 2 weeks after the onset of symptoms. Mean
recorded at every visit. time between the onset of symptoms and maximum
The data collected from the patients were coded anisocoria was 9 days.
and tabulated. Appropriate inferential, descriptive Figure 2: Time taken to develop maximum
statistics, analysis of variance (ANOVA), and anisocoria (the last data point plotted for each patient
correlation were compiled using Statistical Package for (A-I) represents the maximum anisocoria recorded). In
the Social Sciences (SPSS) version 17. The results of the 62.5% of the patients with pupillary involve-
analysis were presented in the form of tables and ment Figure 3, a complete resolution of ophthal-
graphs. The statistical significance is tested at 5% level moplegia was seen (A, B, C, D, and F). Comparison of
(P d<0.05). grades of ophthalmoplegia between different visits by
RESULTS: the Post Hoc test revealed that there was a significant
Of the total 35 subjects screened, none had difference in the ophthalmoplegia grades between the
bilateral oculomotor nerve involvement, and MRI of 1 st and 2nd visit (P = 0.033), the 2 nd and 3 rd visit
(P = 0.002) and the 1st and 3rd visit (P = 0.00). Correlation were done after minimizing variables, which could
analysis (Pearson correlation) didn’t reveal any influence the size of the pupil. The level of scrutiny was
significant association between the course of anisocoria increased by measuring pupil size to the nearest of
and ophthalmoplegia (P = 0.086). Majority of patients 0.5mm in all patients. Additionally, the course of
with pupil involvement didn’t have diabetic anisocoria was compared with that of ophthalmoplegia.
retinopathy changes Table 3. Analysis of data shows that the incidence of pupillary
DISCUSSION: involvement was 25.7%. In a similar study by Jacobson,
The present study was aimed at deriving a reliable
Figure 1
estimate of incidence of pupillary involvement in
diabetes-associated oculomotor nerve palsy. It was
unique in that it was a prospective study unlike many
other previous studies and that pupillary measurements
Characteristis Value
Number Percentage
Pattern
None 24 68.5
Completely resolved 5 14.29
Incompletely resolved 3 8.57
Simple 2 5.71
Lost to follow-up 1 2.8
Total 35 100 Figure 3: Course of ophthalmoplegia
Degree of anisocoria (mm) [The graph represents the grades of ophthalmoplegia of each of the
1 3 33.3 9 patients (A-I) with pupillary involvement at each visit. Patient ‘C’
1.5 3 33.3 and ‘E’ were missed for follow-up at 2nd and 3rd visit, respectively]
2 3 33.3
Number Percentage
No DR 6 66.6
Mild NPDR 2 22.2
Moderate NPDR 0 0
Severe NPDR 1 11.1
PDR 0 0
Total 9 100
DR: Diabetic Retinopathy, NPDR: Non Proliferative diabetic
retinopathy,
PDR: Proliferative diabetic retinopathy
the incidence was found to be 22.7%. 11 But, the ophthalmoplegia over the initial 2 visits. This is in
difference in the incidences, found on comparing our contrast to a study by Jacobson and Broste where an
study with that of Jacobson, was statistically not early progression of ophthalmoplegia was seen in 69%
significant on doing chi square test (P = 0.288). Most of the individuals and mentions that early progression
previous studies quote much lower incidences than that may not be recognized as a common characteristic if
derived from this study and the study by Jacobson.1,3,6,7 the patient is first seen after 1 week of onset of double
The reason for this could be two fold. Most vision.9 The reason for discrepancy between the findings
previous studies chose pupillary reaction to light as the of this study and that of the above-stated study might
primary end point for defining pupil involvement. This be due to the fact that majority of subjects in our study
could have led to underestimation of the pupillary presented to us after 1 week of onset of their symptoms
involvement as reaction of pupil to light could be and also that the subjects were followed up 2 weeks
influenced by various factors, like brightness of light, after their initial visit. Ophthalmoplegia would have
emotional stimuli and accommodation. In this study, already-progressed and then recovered by the time we
the primary end point was anisocoria rather than identified a change from the previous visit to a
pupillary reaction to light. As all other external factors subsequent evaluation. Had all patients been seen on a
which could influence the pupillary size were daily basis, the progression would have been probably
controlled, the difference in size of the involved pupil more evident. It was also inferred that ophthalmoplegia
and the fellow pupil was more accurate in predicting recovers relatively more significantly and much earlier
pupillary involvement than pupillary reaction alone. than anisocoria.
Secondly, in our study, the level of accuracy of pupillary No statistically significant difference was found
measurement was increased by using a pupil gauge between the course of anisocoria and ophthalmoplegia
with a unit measurement of 0.5 mm. Most patients although clinically both anisocoria and ophthalmo-
developed maximum anisocoria within the 1st 2 weeks plegia showed an improvement and resolution at the
after onset of symptoms, which is also similar to the 3rd visit in majority of the subjects. Although the P value
observation in Jacobson’s study.11 However, this time was not significant (P value 0.086), it was close to 0.05,
interval could have been artifactually prolonged as which denotes that a statistically significant association
patients were not followed up on a daily basis. Had all would have been seen had the sample size been more
patients been seen on a daily basis, the maximum in the present series.
anisocoria might have been detected at a much earlier Majority of the patients with pupillary
stage. involvement showed no diabetic retinopathy changes
A fully-dilated, non-reactive pupil is found in 51% or had less severe grades of diabetic retinopathy. A
to 71% of patients with aneurysmal compression of Similar result was reported in a study by Acaroglu et
oculomotor nerve.5,12 In aneurysms compressing the al., in which presence and level of diabetic retinopathy
3rd nerve, anisocoria progresses and the pupil becomes was found to be significantly lower in diabetics with
maximally dilated within the 1 st 2 weeks of the cranial nerve palsy than in the age, sex, and disease-
presentation. A certain number of patients in this study duration-matched controls.13 The relatively milder form
too showed progression of anisocoria during the 1st 2 of diabetic retinopathy could be accounted for by the
weeks of presentation. But, the pupil remained shorter duration of diabetes in the majority of subjects
incompletely involved and variably reactive in all (Mean 7.27 years).
patients in this study. Additionally, none of the patients CONCLUSION:
had an anisocoria of > 2 mm. These characteristics of Pupil involvement in patients with diabetes-
the pupil help to distinguish diabetic from aneurysmal associated oculomotor nerve palsy occurs in about
injury of the oculomotor nerve. From the statistical 1/4th of all cases. Although pupil may be involved in
analysis performed on the course of anisocoria, it can both, certain pupil characteristics like an incomplete
be inferred that the degree of anisocoria normalized involvement and anisocoria < 2 mm may help to
maximally by the 3rd visit (after 8 weeks) as compared distinguish diabetic (ischemic) from aneurysmal
to the 2nd visit (after 2 weeks). While 1 patient was lost (compressive) injury of the oculomotor nerve. Imaging
to follow-up, pupil normalized in a majority of patients may not be required in pupil-sparing oculomotor nerve
(55.5%). The direct pupillary reaction, which was palsies in patients over 50 years with known
impaired during the initial 2 visits, normalized or near vasculopathic risk factors although this is associated
normalized as the ophthalmoplegia reversed and the with the rare risk of missing an aneurysm sparing the
pupil came back to its original size. pupils. These patients could be just treated
Majority of subjects in both pupil-involved and conservatively and followed up on a regular basis, if
pupil-spared groups showed a recovery of possible almost daily for 2 weeks for progression of
More on Line
Read the latest research in Ophthalmology at the following website
www.ophthalmologyupdate.com
Update
ABSTRACT:
A patient, who presented with diplopia after a history of dog bite to the supero-medial part of the eye, had conjunctival
scarring over the medial rectus insertion and symblepharon. He had limitation of depression in adduction, simulating
superior oblique palsy. Unreliability of a three step test in vertical strabismus when there are scars is highlighted.
Key Words: superior oblique palsy; canine tooth syndrome; vertical strabismus; diplopia.
ABSTRACT
Back Ground: Vascular Endothelial Growth Factor (VEGF) appears to be essential for development and maintenance of
functionally efficient retinal vasculature as well as for integrity of the retinal pigment epithelium , Bruch’s membrane and
choroidal endothelial cells. Tissue hypoxia due to primary vascular occlusive disease is the most common driver of VEGF
synthesis and as retinal vein occlusion is associated with increased levels of VEGF, therapy by anti-angiogenics or
vascular endothelial growth factor inhibitors (anti-VEGF) was proposed to be a promising strategy for retinal vein occlusion.
Consequently, several anti-angiogenics have been developed for the treatment of vaso-occlusive disease of retinal vein,
and ophthalmology has witnessed an explosion in the number of intravitreal injections delivered to patients over the past
10 years, driven in large part by the introduction and rapid incorporation of therapy with anti-VEGF agents.
The objective of this review is to evaluate the efficacy of pharmacotherapy by VEGF inhibitors in vaso-occlusive
disorder of retinal vein , in the light of our current scientific knowledge about this disorder.
Key words: vascular endothelial growth factor, vascular endothelial growth factor inhibitors, pharmacotherapy, retinal
vein occlusion.
patients with ischemic CRVO, and are responsible for eligible if they had foveal-involved macular edema from
the increase in vascular permeability that leads to ME4. a BRVO occurring within 12 months of study. Starting
Branch retinal vein occlusion (BRVO) also leads at month 3, patients were eligible for grid laser
to retinal ischemia that induces the production of treatment if hemorrhages had cleared sufficiently to
cytokines such as VEGF by retinal cells such as glial allow safe application of laser.
cells and vascular endothelial cells in the occluded Based upon the NEI VFQ-25 survey, patients who
region affected by anoxia. These cytokines interact with received ranibizumab felt they had greater
each other (cytokine network) and this results in improvement. There was greater reduction of macular
impairment of the blood-retinal barrier and an increase edema in the ranibizumab groups because CPT was
of vascular permeability, considered important in the reduced by 337.3 ìm (0.3 mg) and 345.2 ìm (0.5 mg)
development of macular edema associated with BRVO9. compared to 157.7 ìm in the sham group. In the CRUISE
ANTI-ANGIOGENICS IN RETINAL VEIN Study12, 392 patients with macular edema following
OCCLUSION THERAPY: central retinal vein occlusion (CRVO) were randomized
The term anti-angiogenic therapy was born more to receive monthly intraocular injections of 0.3 mg
than 35 years ago by J. Folkman, who hypothesized that (n = 132) or 0.5 mg (n = 130) of ranibizumab or sham
cancer may be treated by abolishing the nutrients and injections (n = 130).Patients were eligible if they had
oxygen-providing blood vessels and bevacizumab foveal-involved macular edema from a CRVO occurring
became the first therapy approved by the US - FDA within 12 months of study. Patients were excluded if
designed to inhibit angiogenesis in tumors. As retinal they had a brisk afferent pupil defect, had scatter laser
vein occlusion is associated with increased levels of photocoagulation within 3 months, an intraocular
VEGF, anti-VEGF therapy was proposed to be a injection of steroid or a VEGF antagonist within 3
promising strategy for retinal vein occlusion. months, or had an improvement of >10 ETDRS letters
Intraocular injections of a VEGF-binding protein in BCVA between screening and baseline.
reduce vascular leakage, resulting in improvement in Baseline characteristics were well balanced among
macular edema, accelerate resorption of retinal the three groups; the mean age was 68 years, mean
hemorrhages, and prevent worsening of capillary BCVA was 20/100, the mean time from diagnosis of
nonperfusion8,10 There are 4 anti-VEGF agents that are CRVO was 3.3 months, and the mean center point
either approved or in common use in ophthalmology, thickness (CPT) was 685 ìm. Based upon the 25-item
namely ranibizumab (Lucentis-Novartis),bevacizumab National Eye Institute Visual Function Questionnaire
(Avastin-Roche), pegaptanib (Macugen-Pfizer), and NEI VFQ-25 survey, patients who received ranibizumab
aflibercept or VEGF Trap-Eye (EYLEA- Bayer). felt they had greater improvement (improvement from
Lucentis. baseline in NEI VFQ score: 7.1, 0.3 mg; 6.2, 0.5 mg: 2.8,
In June 2006, Lucentis (ranibizumab, Roche/ sham)13. There was greater reduction of macular edema
Genentech) has first received FDA approval for the in the ranibizumab groups because CPT was reduced
treatment of macular edema due to both CRVO and by 433.7 μm (0.3 mg) and 452.3 μm (0.5 mg) compared
BRVO. to 167.7 μm in the sham group. This study demonstrated
Ranibizumab is a humanized, affinity-matured that six sessions of monthly injections of 0.3 mg or 0.5
VEGF antibody fragment that binds to and neutralizes mg reduced macular edema and provided substantial
all isoforms of VEGF.Two phase III multicenter, visual benefit in patients with CRVO.
prospective clinical trials assessing the safety, After the primary endpoint in the CRUISE and
tolerability and efficacy of intravitreal ranibizumab BRAVO trials, patients were evaluated every month and
injections in the treatment of macular edema secondary if study eye Snellen equivalent BCVA was <20/40 or
to BRVO and CRVO 10 were finished. They are called mean CST was >250 μm, they received an injection of
BRAVO (study of the efficacy and safety of ranibizumab ranibizumab; patients in the ranibizumab groups
injection compared with sham in patients with macular received their assigned dose and patients in the sham
edema due to BRVO)11 and CRUISE (study of the group received 0.5 mg. In patients with CRVO, the mean
efficacy and safety of ranibizumab injection compared number of ranibizumab injections during the
with sham in patients with macular edema due to observation period was 3.9, 3.6, and 4.2 in the 0.3 mg,
CRVO) 12. 0.5 mg, and sham/0.5 mg groups; and the percentage
In the BRAVO study 11 397 patients with macular of patients that did not receive any injections during
edema following branch retinal vein occlusion (BRVO) the observation period was 7.0, 6.7, and 4.3,
were randomized to receive monthly intraocular respectively14. At month 12 in the ranibizumab groups,
injections of 0.3 mg (n = 134) or 0.5 mg (n = 131) of the improvement from baseline in ETDRS letter score
ranibizumab or sham injections (n=132). Patients were was 13.9, very similar to the month 6 results, indicating
that vision is well maintained when injections are given (branch RVO) and 2.9, 3.8, and 3.5 (central RVO),
only if there is recurrent or residual macular edema. respectively. The incidence of study eye ocular serious
Patients in the sham group showed substantial adverse events and systemic adverse events potentially
improvement during the observation period when they related to systemic VEGF inhibition across treatment
were able to receive ranibizumab; improvement from arms was 2% to 9% and 1% to 6%, respectively. The
baseline in letter score was 0.8 at month 6 and 7.3 at mean change from baseline BCVA letter score at month
month 12. The percentage of patients who had an 12 in branch RVO patients was 0.9 (sham/0.5 mg), -2.3
improvement from baseline BCVA letter score >15 at (0.3/0.5 mg), and -0.7 (0.5 mg), respectively. The authors
month 12 was 47.0% (0.3 mg) and 50.8% (0.5 mg) in the concluded that no new safety events were identified
ranibizumab groups, almost identical to the month 6 with long-term use of ranibizumab; rates of systemic
results. In the sham group, 33.1% of patients improved adverse events potentially related to treatment were
from baseline >15 in letter score at month 12 compared consistent with prior ranibizumab trials. Reduced
to 16.9% at month 6. At month 12, 43% of patients in follow-up and fewer ranibizumab injections in the
the two ranibizumab groups had a Snellen equivalent second year of treatment were associated with a decline
BCVA of 20/40 compared to 35% in the sham/0.5 mg in vision in central RVO patients, but vision in branch
group. RVO patients remained stable. Results suggest that
In patients with BRVO, the mean number of during the second year of ranibizumab treatment of
ranibizumab injections during the observation period RVO patients, follow-up and injections should be
was 2.9, 2.8, and 3.8 in the 0.3 mg, 0.5 mg, and sham/ individualized and, on average, central RVO patients
0.5 mg groups; and the percentage of patients that did may require more frequent follow-up than every 3
not receive any injections during the observation period months.
was 17.2, 20.0, and 6.5, respectively15. At month 12 in In addition, the sub-analyses in BRAVO and
the ranibizumab groups, the improvement from CRUISE study generally confirmed that patients with
baseline in ETDRS letter score was 16.4 (0.3 mg) and BRVO or CRVO who were younger or who had worse
18.3 (0.5 mg), very similar to the month 6 results, vision and greater retinal thickness at baseline fared
indicating that vision is well maintained when injections better. Patients with BRVO fared better if time from
are given only if there is recurrent or residual macular diagnosis to treatment was less than 3 months. Patients
edema. Patients in the sham group showed substantial with CRVO had similar results regardless of time to
improvement during the observation period when they treatment.
were able to receive ranibizumab; improvement from In general, then, in BRVO, patients who needed
baseline in letter score was 7.3 at month 6 and 12.1 at fewer therapies, such as laser or other previous
month 12. The percentage of patients who had an treatments, probably had milder RVO requiring less
improvement from baseline BCVA letter score >15 at treatment. Patients who were younger did better than
month 12 was 55.2% (0.3 mg) and 61.1% (0.5 mg) in the those who were older,and patients with CRVO had a
ranibizumab groups, almost identical to the month 6 more unpredictable course than those with BRVO, and
results. In the sham group, 43.9% of patients improved therefore warrant even closer observation than those
from baseline >15 in letter score at month 12 compared with BRVO 38.
to 28.8% at month 6. At month 12, 67.9% (0.3 mg) and Avastin:
64.4% (0.5 mg) of patients in the ranibizumab groups Avastin(bevacizumab (Avastin), is FDA-
had a Snellen equivalent BCVA of 20/40 compared to approved for the treatment of colorectal cancer.
56.8% in the sham/0.5 mg group. Thus, in both CRUISE However, because the agent costs substantially less per
and BRAVO, patients in the sham groups showed a dose than Lucentis, it has been widely used off-label
substantial improvement in vision during the second 6 since 2004 to treat several retinal diseases, including
months when they were able to receive ranibizumab as retinal vein occlusion.Bevacizumab is a recombinant
needed, but their vision at month 12 was not as good as humanized monoclonal antibody directed against
that in patients in the ranibizumab groups. This raises VEGF. Recently, Ghayooret al.18 evaluated the effect of
a question as to whether delay in treatment carries a Avastin (mean 2.8 injections) in 8 eyes with CRVO- and
visual penalty. 22 with BRVO-associated macular edema and claimed
The results from open-label extension trial of the that significant improvement in best corrected VA was
12-month Ranibizumab assessing long-term safety and observed at 6th week of follow-up. At 6th month more
efficacy in BRAVO and CRUISE trials 16 evidenced that than 60% showed improvement in best corrected visual
in patients who completed month 12, the mean number acuity, similarly 70% patients had complete resolution
of injections (excluding month 12 injection) in the sham/ of macular edema. The authors concluded that anti-
0.5-, 0.3/0.5-, and 0.5-mg groups was 2.0, 2.4, and 2.1 VEGF therapy should be further evaluated in large,
prospective, controlled clinical studies. 0.3 or 1 mg at baseline and at weeks 6 and 12 with
At the latest prospective study Dallen et al.19 subsequent injections at 6-week intervals at the
evaluating the 12-month outcome and predictive factors discretion of the investigator until week 48. He also
of visual acuity (VA) changes following bevacizumab found improvements in VA and macular thickness in
therapy for CRVO concluded that early injections of this study with a 54-week follow-up. Therefore, the
bevacizumab in young patients in whom VA is authors consider that intravitreal pegaptanib offers a
relatively preserved leads to a significant improvement promising alternative for macular edema secondary to
in VA. Ischaemic CRVO and poor baseline VA are BRVO.
associated with non-response to such therapy. VEGF Trap:
Epstein et al.20 conducted the latest prospective The VEGF trap is another novel anti-VEGF agent
double-masked clinical trial of 60 patients with macular aflibercept (Eylea, Regeneron) . It is essentially a small
edema secondary to CRVO randomized 1:1 to receive fully human, soluble VEGF receptor that acts as a decoy
intraocular injections of bevacizumab or sham injection receptor binding-free VEGF. Aflibercept was approved
every 6 weeks for 6 months.Results evidenced that the for macular edema following CRVO in September 2012.
treatment improve VA and reduce macular edema The VEGF trap eye is currently under evaluation in two
significantly compared with sham.The International phase III studies on CRVO (GALILEO and
Intravitreal Bevacizumab Safety Survey gathered COPERNICUS Studies) with 6-monthly injections of
adverse events from doctors around the world via the drug or sham-controlled injections. The latest six-
internet 21 and showed all ocular and systemic side months results of the Phase 3 from COPERNICUS
effects to be under 0.21% including corneal abrasion, Study - multicenter, randomized, prospective,
lens injury, endophthalmitis, retinal detachment, controlled trial 25,26 assessing the efficacy and safety of
inflammation or uveitis, cataract progression, acute intravitreal Trap-Eye in 189 eyes with macular edema
vision loss, central retinal artery occlusion, sub-retinal secondary to central retinal vein occlusion (CRVO)
haemorrhage, retinal pigment epithelium tears, blood randomized 3:2 to receive VEGF Trap-Eye 2 mg or sham
pressure elevation, transient ischaemic attack, injection monthly for 6 months evidenced that at week
cerebrovascular accident and death. Fung. et al. 21 24, 56.1% of VEGF Trap-Eye treated eyes gained 15
concluded that self-reporting of adverse events after letters or more from baseline versus 12.3% of sham-
intravitreal bevacizumab injections did not show an treated eyes (P<0.001). The VEGF Trap-Eye treated eyes
increased rate of potential drug-related ocular or gained a mean of 17.3 letters versus sham-treated eyes,
systemic events and these short-term results suggest which lost 4.0 letters (P<0.001). Central retinal thickness
that intravitreal bevacizumab seems to be safe. decreased by 457.2 ìm in eyes treated with VEGF Trap-
Macugen: Eye versus 144.8 ìm in sham-treated eyes (P<0.001), and
In 2004, Macugen (pegaptanib sodium-Pfizer and progression to any neovascularization occurred in 0 and
OSI/Eyetech Pharmaceuticals, Inc.) was the first anti- 5 (6.8%) of eyes treated with VEGF Trap-Eye and sham-
VEGF agent to receive FDA approval for the treatment treated eyes, respectively (P = 0.006). Conjunctival
of neovascular age-related macular degeneration hemorrhage, reduced visual acuity, and eye pain were
(AMD). Macugen is a selective anti-VEGF compound the most common adverse events .Serious adverse
that is designed to inhibit one strain of VEGF. It should effects ocular were reported by 3.5% of VEGF Trap-Eye
be administered via intravitreal injection every six patients and 13.5% of sham patients. Incidences of
weeks. Although the use of Macugen has declined with nonocular serious adverse events generally were well
the release of newer anti-VEGF agents, such as Lucentis balanced between both groups. The authors concluded
and Avastin, it appears to be making a comeback that at 24 weeks, monthly intravitreal injection of VEGF
because of its more favorable dosing frequency (e.g., Trap-Eye 2 mg in eyes with macular edema resulting
every six weeks vs. every four weeks). Additionally, from CRVO improved visual acuity and central retinal
Macugen is associated with a lower risk of stroke than thickness, eliminated progression resulting from
either Lucentis or Avastin22. The pegaptanib sodium is neovascularization, and was associated with a low rate
still not well studied in RVO. Bennet23 performed a pilot of ocular adverse events related to treatment. Dr.
study where Macugen treatment achieved a decrease Korobe lnik presented the results on behalf of the
in macular thickness and an improvement in VA and GALILEO investigators at the annual meeting of the
retinal perfusion. But this study had enrolled only 7 American Academy of Ophthalmology 27 GALILEO is
patients with 6 months of follow-up and it had no a double-masked study conducted at 62 centers in
control group. On the other hand, Wroblewski et al. 24 Europe and Asia. It randomly assigned 177 patients 3:2
conducted a study where subjects with BRVO were to receive intravitreal aflibercept 2 mg or sham every 4
randomized 3:1 to intravitreal injections of pegaptanib weeks until week 24. Between week 24 and 52, patients
continued monthly monitoring, but the aflibercept eyes earlier reports of multicentre studies, outcome of
received treatment as needed while the sham group patients is relatively poor in the current treatment
continued to receive sham treatment every 4 weeks. settings 30 .
From weeks 52 to 76, the inter-visit interval was The preparation of the intravitreal injection site
extended to 8 weeks and sham patients were eligible with topical povidone-iodine is the preferred
for aflibercept. Nearly three-fourths of sham eyes and prophylactic method to minimize the risk of
85% of the aflibercept eyes completed 76 weeks of endophthalmitis. There is no need for topical antibiotic
follow-up. During the first 24 weeks of GALILEO, use after intravitreal injection. Additional infrequent
monthly aflibercept treatment resulted in rapid and complication includeanaphylactic reaction to the agent
sustained gains in best-corrected visual acuity28. The injected in the vitreous. A 2006 national survey in USA
improvement was largely maintained through week 52, Complications reported following complications rate
but declined some between weeks 52 and 76. Similar associated with intravitreal injections: endophthalmitis
temporal patterns were seen in analyses of changes in - 31%, increased IOP - 26%, cataract - 11%,other - 16%
central retinal thickness (CRT) and proportion of eyes 31. The most important adverse local effects related to
without retinal fluid in the aflibercept treatment group. anti-VEGF agents include uveitis, retinal detachment
After becoming eligible for aflibercept, eyes in the and cataracts.
sham group gained vision and had decreased CRT. The latest study32 on the rate of serious adverse
However, outcomes at week 76 were superior in the effects in a series of bevacizumab and ranibizumab
eyes that had been treated with aflibercept since entry. injections revealed that subjects who received
Results from follow-up to 76 weeks in the phase III bevacizumab were 12 times more likely to develop
GALILEO study show that intravitreal injection of severe intraocular inflammation following each
aflibercept (Eylea, Regeneron Pharmaceuticals) injection than were those who received ranibizumab.
provides marked improvement in visual acuity in One of acute intraocular inflammation following
treatment-naive eyes with macular edema secondary ranibizumab injection was mild and not associated with
to central retinal vein occlusion. However, the data also vision loss. No other serious ocular complications were
suggest the value of close monitoring and early noted. A trend was also noted toward an increased risk
treatment. The results of GALILEO and COPERNICUS for arterial thrombo embolic events in patients receiving
are encouraging for patients with central retinal vein bevacizumab, although the confidence interval was
occlusion. wide. In conclusion, authors stated that significant
Potential Hazards of Anti-VEGF Therapy: concern still exists regarding the safety of off-label use
Local adverse effects: Intravitreal injections of of intravitreal bevacizumab. Patients receiving
various agents have been studied extensively. The bevacizumab should be counseled regarding a possible
overall risk of complications are low when the injection increased risk for serious adverse events. Anti-VEGF
is administered by experienced ophthalmologists. therapy may therefore have adverse effects on ocular
Known risks of intravitreal injections can be vision blood flow. Von Hanno et al.33 presented two cases of
threatening and require prompt diagnosis and retinal artery occlusion after intravitreal injection of
treatment, possibly surgical intervention. The most bevacizumab (Avastin) and ranibizumab (Lucentis)
serious but rarely occurring injection-related respectively and concluded that the therapeutic
complications include acute-onset endophthalmitis, principle may be associated with an increased risk of
pseudo-endophthalmitis, cataract development/ retinal arterial occlusions.
progression, retinal detachment, and hemorrhage. Leung et al.34 presented a series of three patients
Additional infrequent complications include hypotony, of the nearly 200 patients with CRVO who suffered
angle closure, hemi-retinal vein occlusion, retinal apparent macular infarction within weeks of intravitreal
pigment epithelial tears, iritis/uveitis, optic disc administration of bevacizumab. The authors stated that
atrophy, corneal epitheliopathy, maculopathy central this has not been described in the natural history of the
retinal artery occlusion.The latest study 29 revealed that disease and is associated with poor visual outcomes.In
endophthalmitis following intravitreal injection is Manousaridis and Talks35 opinion worsening of macular
associated with an increased incidence of Streptococcus ischaemia in the long term cannot be definitely
spp. infection, earlier presentation and poorer visual excluded, particularly in eyes with significant ischaemia
outcomes when compared with endophthalmitis at baseline and after repeated intraocular anti-VEGF
following cataract surgery. Irigoyenet al.30 concluded injections. The decision to offer prolonged anti-VEGF
that the overall numbers of patients with treatment in cases of significant coexisting macular
endophthalmitis following intravitreal injections has ischaemia should not be based only on measurements
risen dramatically over the past years. In contrast to of macular thickness; instead repeat fluorescein
angiograms should be performed. In conclusion, the agents, ophthalmologists and nephrologists should be
overall risk of complications is low when the injection aware of the associated risk of kidney disease. Early
is administered by experienced ophthalmologists . detection is crucial so that intravitreal injections can be
Tachyphylaxis/tolerance: stopped before severe kidney disease occurs. In
The worldwide use of intravitreal application of Sorenson and Sheibani41 opinion perhaps baseline and
anti-vascular growth factor and the realisation that renal function during treatment (serum creatinine and
regular applications over long periods of time are urinary protein levels, blood pressure) should be
necessary to maintain vision in these eyes, has revealed carefully monitored to ensure that the improved visual
the problem of tolerance/tachyphylaxy36. Binder S.36 acuity is not at the expense of renal function.
recommended different options to prevent Concerns with anti-VEGF therapy:
tachyphylaxis/tolerance: (1) to increase the dosage or Major concerns with anti-VEGF therapy for ocular
shorten treatment intervals if tolerance has developed; diseases include: repeat intravitreal injections; risk of
(2) to pause treatment if tachyphylaxis has occurred; cardiovascular complications; possible retinal and
(3) to combine drugs with different modes of action; or neural toxicity due to cumulative dosing; interference
(4) to switch to a similar drug with different properties with physiologic functions of VEGF; and economic and
(bevacizumab and ranibizumab differ in molecular size, cost-effectiveness concerns. Tailoring treatment to the
affinity and absorption). individual patient should increase the chance of
Systemic adverse effects: treatment success, while sparing patients from
While used intravitreally, the systemic absorption unnecessary drug exposure and risk of adverse events.
is minimal, however, a trend has been observed towards Furthermore, avoiding unnecessary treatment also has
a higher risk of stroke among patients with a history of the potential to improve the cost-effectiveness of
heart disease24. Campbell et al.37 assessing the risk of treatment 42.
systemic adverse events associated with intravitreal Lang43 also stated that it is important to make
injections of VEGF inhibiting drugs in the nested case- decisions about the best treatment in retinal vein
control study have found that intravitreal injections of occlusion, which necessitates knowledge of the
bevacizumab and ranibizumab were not associated posology of the drug and assessment of the advantages
with significant risks of ischaemic stroke, acute and risks of the different treatment modalities.
myocardial infarction, congestive heart failure, or Therefore it is important to know the efficacy and safety
venous thrombo embolism. Clinical evaluation of data of the therapy. In conclusion, patients should
ranibizumab (Lucentis) based on two double-blind discuss the potential risks and benefits of
randomised trials comparing ranibizumab (0.3 mg or intravitrealpharma-cotherapy with their physicians
0.5 mg) versus placebo in a total of 795 patients revealed before receiving treatment.
that the incidence of heart failure and transient CONCLUSION
ischaemic attacks was higher during the second year of Vascular endothelial growth factor, a key
ranibizumab therapy than during the first year of regulator of angiogenesis and vascular permeability has
treatment 38. Patients should be informed of the potential been implicated in the pathogenesis of retinal diseases
adverse effects and uncertainties and be reminded that associated with neo-vascularisation and edema. As
this condition improves spontaneously in about 50% of retinal vein occlusion is associated with increased levels
cases 38 or almost in one quarter of affected eyes at 3 of VEGF, anti-VEGF therapy was proposed to be a
years 39 further controlled and prospective studies are promising strategy for retinal vein occlusion.
necessary to compare treatment by Lucentis to the Consequently, several anti-angiogenics have been
natural course with a longer follow-up39 There is some developed for the treatment of vaso-occlusive disease
evidence that intravitreal anti-VEGF injections may of retinal vein. Treatment regimens have evolved
result in systemic absorption, with the potential for through experience gained in clinical trials and clinical
injury in organs that are reliant on VEGF, such as the practice. The current treatment regimen for RVO should
kidney. Pellé et al.40 reported the first case of a patient reflect an individualized treatment approach designed
who developed an acute decrease in kidney function, to treat patients when they could benefit the most while
non-immune micro-angiopathic hemolytic anemia with minimizing the number of unnecessary intravitreal
schistocytes, and thrombocytopenia after 4 intravitreal injections, and hence the risk of adverse events.
injections of ranibizumab. Light microscopy of a kidney Selection of appropriate therapeutic procedure
biopsy specimen showed segmental duplications of based on the evidence- based medicine, to protect and
glomerular basement membranes with endothelial improve visual function of patients with retinal vein
swelling and several recanalized arteriolar thrombi. occlusion are the important project of clinicians and
Because of the increasing use of intravitreal anti-VEGF require further exploration and investigation
36. Binder S.Loss of reactivity in intravitreal anti-VEGF therapy: S, Frémeaux-Bacchi V, Hiesse C, Delahousse M. Systemic
tachyphylaxis or tolerance? Br J Ophthalmol 2012;96:1-2. and kidney toxicity of intraocular administration of vascular
37. Campbell RJ, Gill SS, E Bronskill SE, Paterson JM, Whitehead endothelial growth factor inhibitors. Am J Kidney Dis
M, Bell CM. Adverse events with intravitreal injection of 2011.;57(5):756-9
vascular endothelial growth factor inhibitors: nested case- 41. Sorenson CM, Sheibani N. Anti–Vascular Endothelial Growth
control study. BMJ2012;345:e4203 Factor Therapy and Renal Thrombotic Microangiopathy.
38. Ranibizumab and retinal vein occlusion. Too many ArchOphthalmol2011.;129(8):1082.doi:10.1001/archo-
outstanding questions. Prescrire Int. 2012;21(130):207. phthalmol. 2011.199.
39. Puche N, Glacet A, Mimoun G, Zourdani A, Coscas G, 42. Brand CS. Management of retinal vascular diseases: a patient-
SoubraneG.Intravitrealranibizumab for macular oedema centric approach. Eye (Lond). 2012; 26(S2): S1–S16
secondary to retinal vein occlusion: a retrospective study of 43. Lang GE. New developments in the pharmacological
34 eyes. ActaOphthalmol. 2012 Jun;90(4):357-61. treatment of macular oedema due to retinal vein occlusion.
40. Pellé G, Shweke N, Duong Van Huyen JP, Tricot L, Hessaïne Klin Monbl Augenheilkd. 2011 Sep;228(9):793-800.
Mydriasis in the
Garden
Aaron Vunda, M.D.
Gabriel Alcoba, M.d.
University Hospitals of Geneva
Geneva, Switzerland
ABSTRACT
Objective: To determine the frequency of Intraocular pressure changes after Phacoemulsification in patients having age
related cataract.
Materials and Methods: This study was conducted at ophthalmology department, PGMI, Lady Reading Hospital, Peshawar,
from 15 th Sep, 2010 to 15 th June, 2011. 130 patients suffering from age-related cataract with age range from 45 to 75years
were selected, mean age of the patients were 52 years with standard deviation ± 2.57,in which 69 (53%) were male and
61 (47%) were female. Informed consent was obtained from each patient. A proper proforma was designed for evaluation
and documentation of patients. Anterior segment and if possible posterior segment examination was done with direct,
indirect ophthalmoscope and slit lamp bimicroscopy. Biometry and viral profile was done. All the patients were operated
by Phacoemulsification and intraocular lens were implanted in the capsular bag. Pre and postoperative intraocular pressure
was measured with the help of applanation tonometer. The first postoperative intraocular pressure was taken as final
reading.
Results:In this study mean age of the patients was 52 years with standard deviation ± 2.57, 53% patients were male and
47% patients were female. Pre operative intra ocular pressure was analyzed as 42% patients had IOP ranged from 11-16
mmHg and 58% patients had IOP ranged from 17-21 mmHg. Post operatively change in the intra ocular pressure was
increased in 36% patients by 5 mmHg or more while in 64% patients IOP remained the same.
Conclusion: Increase in intraocular pressure occurs frequently after uncomplicated phacoemulsification cataract surgery
performed for patients with age related cataract. This rise in intraocular pressure can cause damage to the ocular structures.
Intraocular pressure is not routinely measured after phacoemulsification. It is recommended that intraocular pressure
should be measured on the first postoperative day after phacoemulsification routinely. Moreover, the patients should also
be given pressure lowering medicines in the postoperative period after phacoemulsification to prevent ocular damage
due to intraocular pressure spikes.
Key words:
Intraocular Pressure, phacoemulsification, age related cataract.
capsulorrhexis, maintenance of anterior chamber, mostly in age range from 51-60 years followed by
protection of corneal endothelium, acting as temponade 37(28%) patients above 60 years and 34(26%) patients
for intraocular structures, protection of posterior were in age range from 40-50 years. Mean age was 52
capsule from sharp edge of broken nuclear fragments, years with standard deviation ± 2.57. (Table I) Gender
and filling of capsular bag before Intraocular lens distribution among patients 69 (53%) were male while
implantation OVDs used in phacoemulsification can 61(47%) patients were female. (Table II)
cause various adverse effects, the most common and Visual acuity findings among patients 102 (78%)
potentially dangerous of them is the transient rise in ranged from < 6/18 – 6/60 while 28(22%) patients had
IOP in post-operative period. OVDs cause elevation of visual acuity ranged from counting fingers to
IOP in the postoperative period due to clogging of perception of light. (Table III)
trabecular meshwork10. Preoperative intra ocular pressure (IOP) in 55
Phacoemulsification is the surgical procedure of (42%) patients ranged from 11-16 mmHg while in 75
choice for management of age related cataract and rise (58%) patients it was from 17-21 mmHg. Mean intra
in IOP is one of the common complications of this type ocular pressure (IOP) was 17 mmHg with standard
of surgery. IOP is not routinely checked after deviation ± 1.34 (Table IV). Post operatively change in
phacoemulsification. The rationale of our study is to the intra ocular pressure was analyzed as in 47 (36%)
find out the change in IOP postoperatively in patients patients intra ocular pressure had increased by 5 mmHg
having age related cataract undergoing or more. while in 83 (64%) patients Intra ocular pressure
phacoemulsification and to make it a routine practice was not changed. Mean intra ocular pressure after the
to check IOP postoperatively because high IOP may change was 19 mmHg with standard deviation ± 2.78
damage the ocular structures and this damage may be (Table V)
irreversible. Postoperative change in the intra ocular pressure
MATERIALS AND METHODS among 47(36%) patients was compared with age
This cross sectional study was conducted in distribution as IOP was increased by 5mmHg or more
department of Ophthalmology, PGMI, Lady Reading in 10(8%) patients who were in age range between 40-
Hospital, Peshawar, from 15th Sep, 2010 to 15th June, 50 years, 24(18%) patients who were in age range from
2011. 130 patients suffering from age related cataract 51-60 years and 13(10%) patients who were above 60
with age range from 45 to 75years were selected, mean years of age. (Table VI)
age of the patients were 52 years with standard Postoperative change in the intra ocular pressure
deviation ± 2.57, in which 69 (53%) were male and 61 among 47(36%) patients was compared with gender
(47%) were female (Table II). distribution as IOP was increased by 5mmHg or more
Preoperative visual acuity (Table III) and in 23(18%) male patients and in 24(18%) female patients.
intraocular pressure (Table IV) were checked. Informed (Table VII) Postoperative change in the intra ocular
consent was obtained from each patient. A proper pressure among 47(36%) patients was further analyzed
proforma was designed for evaluation and as IOP was increased by 5mmHg or more in 22(17%)
documentation of patients. patients who had IOP ranged from 11-16 mmHg and
Anterior segment and if possible posterior 25(19%) patients who had IOP ranged from 17-21
segment examination was done with direct, indirect mmHg. (Table VIII)
ophthalmoscope and slit lamp bimicroscopy. Biometry
and viral profile was done. All the patients were Table I showing age wise distribution. Total 130
operated by Phacoemulsification and IOL were
implanted in the posterior chamber. Diabetics, Age wise distribution Frequency Percentage
hypertensive, glaucomatous, old cases of ocular trauma 40 to 50 years 34 26%
and co-ocular morbidity patients were excluded from
51-60 years 59 46%
the study.
Pre and postoperative intraocular pressure was More than 60 years 37 28%
measured with the help of applanation tonometer. The Total 130 100%
first postoperative intraocular pressure was taken as a
Table II showing gender wise distribution. Total 130
final reading.
RESULTS
Gender Frequency Percentage
This study was conducted at Department of
Male 69 53%
Ophthalmology, PGMI, Lady Reading Hospital,
Peshawar. A total of 130 patients were included in this Female 61 47%
study. Age distribution among patients 59(46%) were Total 130 100%
Change in IOP Versus Age distribution Pts with no change in IOP Pts with change in IOP Total Patients
Change in IOP versus Gender distribution Patients with no change in IOP Patients with change in IOP Total Patients
Change in IOP Patients with no change in IOP Patients with change in IOP Total Patients
11- 16 mmHg 33 (25%) 22 (17%) 55 (42%)
ABSTRACT
Purpose: To evaluate complications and visual improvement in patients undergone extracapsular cataract extraction in
District Head Quarter Hospital, Battagram, Khyber Pakhtoonkhawa.
Material and Methods: A total of 1150 patients having cataracts were examined from outpatient department of District
Head Quarter Hospital, Battagram from October 2009 to December 2010. Patients were thoroughly examined and
investigated. All patients underwent manual extracapsular cataract extraction with intraocular lens implantation by the
same surgeon. Intraoperative, postoperative complications and visual acuity at the end of 1 st, 2nd , 4th, 6th week and after
removal stitches, were noted.
Results: Of the total 1150 patients 972 completed 6 weeks for follow up period. The most common intraoperative
complication was posterior capsular rent that occurred in 23(2%) cases followed by rise of intraocular pressure in 7
(0.6%) cases. Corneal edema was the most common postoperative complication, occurred in 26(2.26%) cases followed
by iris prolapse 9(0.78%), inflammatory glaucoma 3(0.26%), IOL drop 2(0.17%) and endophthalmitis in 2(0.173%) cases.
Visual acuity of better then 6/60 achieved in 94.54% of patients.
Conclusion: Manual extracapsular cataract extraction with IOL is a safe and effective technique for the treatment of
cataract in peripheral set up.
Inclusion criteria: these patients the most common cause was cough and
All patients with operable cataracts in one or both breathing difficulty (Table 5).
eyes affecting their routine activities. Postoperative complications were in following
Exclusion criteria: order of frequency, Corneal edema 26 (2.26%), iris
i. Patients with afferent papillary defect, total and prolapse 9 (0.78%), endophthalmitis 2(0.173%), pupil
relative. block inflammatory glaucoma 3(0.26%) and Intraocular
ii. Central corneal opacities lens drop 2(0.17%). (Table: 6)
Patients were admitted through OPD. Thorough Final visual acuity achieved at 6th weeks after
preoperative evaluation was carried out with Snellen removal of stitches were good in (6/6- 6/9) in
chart or light perception or projection, Slit lamp, direct 677(69.65%) patients, fair (6/9-6/18) and in 184
and indirect ophthalmoscopes. (18.93%) these patients had either developed
Systemic evaluation including blood pressure
check up and diabetes screening were done. Blood Table 1: Gender distribution
samples of all patients were tested for Hepatitis B and
C viruses. Keratometry and intraocular lens powers Sex Number of patients %age
were calculated. Two types of anesthesia was used i.e. Male 656 57.04%
peribulbar and subconjunctival anesthesia depending
Female 494 42.90%
upon the patients choice and tolerability. In cases of
peribulbar anesthesia ocular compression was achieved Table 2: Visual impairment at presentation
through compressed cotton balls.
Conventional extracapsular cataract extraction Level of visual impairment Number of patients %age
with posterior chamber intra ocular lens implantation
was the surgical procedure. Intraoperative Severe (6/60 or worse) 897 78%
complications were noted. Post operative follow up was Moderate(6/24-6/18) 207 18%
carried out on 1st, 2nd, 4th and 6th weeks. Final visual Mild (6/18-6/9) 46 4%
acuity on the last follow up after removal of stitches
was noted. Table 3: Cataract morphological presentation
RESULTS
Total of 1150 patients were operated. Out of these Type of cataract Number of patients %age
656 (57.04%) were male and 494(42.9%) were females
Mature 908 78.9%
(Table 1). Mean age was 58 years. Hence comprehensive
eye care unit of District Headquarters Hospital, Cortical 138 12%
Battagram is a unit where all surgical consumables like Nuclear 69 6%
intraocular lenses, sutures, viscoelastics etc are
Sub capsular 35 3.04%
provided free of cost. To get benefits of these free
facilities patients come from far flung areas. Table 4: Associated co-morbidities
Preoperative visual acuity of 6/60 or less was
noted in 78%, 6/18-6/60 in 18% and 6/9-6/18 in 4% of Morbidities Number %age
cases (Table 2). Mature cataract was the most common
Systemic hypertension 59 5.12%
presentation i.e. 908 (78.9%) of cases, followed by
cortical 138 (12%), nuclear 69 (6%) and posterior sub- Diabetes mellitus 41 3.6%
capsular in 35 (3.04%) of cases (Table 3). Glaucoma 36 3.12%
The most common associated diseases were
Pterygium 20 1.73%
systemic hypertension in 59 (5.12%), diabetes mellitus
in 41 (3.6%), glaucoma in 36 (3.12%), pterygium in 20 Chronic Dacryocystitis 26 2.26%
(1.73%) and chronic dacryocystitis in 26 (2.26%). HBsAg Hepatitis B +ve 9 0.78%
positive was positive in 9(0.78%) and HcV positive were
Hepatitis C +ve 93 8.03%
93 (8.03%).( Table 4)
Posterior capsular rent was the most common Table 5: Intraoperative complications
intraoperative complication occurring in 23 (2%)
patients, with out vitreous prolapse in 14 (1.21%) and Complications Number %age
with vitreous prolapse in 9 (0.78%), followed by sudden
Posterior capsular rent 23 2.0%
rise of intraocular pressure and shallowing of anterior
chamber without vitreous loss in 7(0.6%) patients, in Rise of intraocular pressure 7 0.6%
funded option for cataract surgery in Mysore, India. Lanset phacoemulsification and manual extracapsular cataract
2000. 355: 180-4. extraction. J Cataract Refract Surg 2003; 532-36.
6. Albanis CV, Dwyer MA, Earnes JT. Outcomes of ECCE and 13. Guzek J Ching A. Small-incision Manual Extracapsular
phacoemulsification performed in university training Cataract Surgery in Ghana, West Africa. J Cataract Refract
program. Ophthalmic Surg Laser 1998; 29(8): 643-8 Surg 2003; 57-64.
7. Kanski JJ. Lens. Kanski JJ Clinical Ophthalmology: A systemic 14. Alexandraxis G, Balachander R. Simultaneous bilateral
approach. 6th ed. Edinburg: Butterworth Henmann 2006; 12: Extracapsular Cataract extraction. Ann Ophthalmol 1987; 21:
313-67. 564-68.
8. Mpyet C. Extracapsular cataract extraction with and without 15. Chitkara DK, Smerdon DL. Risk factors, complications and
IOL implantation: Visual outcomes and complications. results in Extracapsular Cataract extraction. J Cataract Refract
Nigerian J Ophthalmol; 14: 9-12. Surg 1997; 24(4): 570-4.
9. Dorothy S, Fan P, Kenneth K. Retinal complications after 16. Ionides A, Minnasain D, Tuft S. Visual outcome following
cataract extraction in patients with high myopia. Ophsource posterior capsular rupture during cataract surgery. Br J
1998; 1069(4):688-92. Ophthalmol 2001; 85: 222-4.
10. Thylefors B. Avoidable blindness. Bull World Health Org 17. Allen AW, Zhang HR. Extracapsular cataract extraction:
1999; 77(6): 453. prognosis and complications with and without posterior
11. West SK, Valmadrid CT. Epidemiology of risk factors for age chamber intraocular lens implantation. Ann Ophthalmol
related cataract. Surv Ophthalmol 1995; 39: 323-34. 1987; 19(9) : 329-33
12. Basti S, Garg M. Posterior capsular dehiscence during
ABSTRACT
Objective: To evaluate the change in visual acuity and IOP after Nd: YAG laser posterior capsulotomy.
Material and Method: This cross sectional study was conducted at out patient department of LRBT Free Secondary Eye
Hospital Mansehra from May to November 2012. In this study 200 patients were included who had posterior capsular
opacity (PCO) after cataract surgery. All the patients had undergone Nd: YAG laser posterior capsulotomy, Visual acuity
and IOP were checked before the procedure, one hour after the procedure and one week after the procedure (as a final
reading of visual acuity and IOP).
Results: In this study the mean age of the patients was 58.58 years with standard deviation ±11.56 SD.60% patients
were male while 40% patients were female. Improvement in the final visual acuity was present in 84.5% of the patients
while 15.5% patients showed no improvement in the final visual acuity. Regarding the change in IOP after NdYAG laser
posterior capsulotomy, 104(52%) patients showed no change in IOP, 68 (34%) patients showed 1-4 mmHg increase in
IOP,while 28(14%) patients showed increase of more than 5mmHg in IOP which needed special attention and regular
follow up till IOP was controlled.
Conclusion: The results of the study suggests that visual acuity in patients who had developed posterior capsular opacity
after cataract extraction with posterior chamber intraocular lens implantation is better after Nd: YAG laser posterior
capsulotomy than the visual acuity before the use of Nd: YAG laser posterior capsulotomy. Regarding the change in IOP
after Nd:YAG laser posterior capsulotomy, 104(52%)of the patients showed no change in IOP, 68 (34%) patients showed
1-4 mmHg increase in IOP, while 28(14%) patients showed increase of more than 5mmHg in IOP which needed special
attention and regular follow up till IOP was controlled.
Abbreviation / Key words: IOP (Intra ocular pressure), Nd: YAG laser (Neodymium: Yatrium Aluminium Garnet laser),
PCO (Posterior Capsular Opacity), VA (Visual Acuity)
capsulotomy were included in the study. Purposive according to thickness of capsule until an opening was
(non- probability sampling) technique was used in this achieved.
study. Following the capsulotomy 0.1% diclofenic
Inclusion criteria sodium (Naclof) eye drops were advised thrice in a day
1. All patients having uneventful cataract surgery for one week and anti glaucoma therapy advised when
with posterior chamber IOL implant followed by needed. Then patients were reviewed for assessment
development of posterior capsular opacification. of visual acuity and measurement of IOP one hour
2. Patients having more than six month’s follow-up after and one week after the laser treatment.
after cataract surgery. The cases that satisfied the inclusion criteria were
Exclusion criteria included. Data was entered and analyzed using SPSS
1. Patients below 20 years of age. version 10. Mean and standard deviation were
2. Patients having less than six month’s follow-up calculated for numerical variable i.e. age wise
after cataract surgery. percentages and frequencies were computed for
3. Extra capsular cataract extraction without IOL categorical variable like age of the patients and sex etc.
implantation. The entire variables were presented in the form of tables
4. Known cases of glaucoma like POAG and primary and charts. A p-value <0.05 was considered as
angle closure glaucoma (PACG) statistically significant.
5. Dislocated/sub-luxated IOL. RESULTS:
6. IOL implant in traumatic cataract. This study was conducted at out-patient
7. Patients having combined procedure department of LRBT Free Secondary Eye Hospital
(Trabeculectomy with PC IOL). Mansehra in which a total of 200 patients undergoing
8. Patients diagnosed as a case of diabetic Nd: YAG laser posterior capsulotomy were included
retinopathy or any other retinal disease. in the study and the results were analyzed.
9. Cases with postoperative complications such as Age distribution among 200 patients were
endophthalmitis. analyzed as n=48 (24%) patients were in age ranged
Approval was taken from ethical committee of between 40 – 49 years, n=50 (25%) in age range between
LRBT Central office Karachi, before starting the study. 50-59 years, n=70 (35%) in age range between 60 -69
200 patients suffering from posterior capsular opacity years and n=32(16%) in age equal or above 70 years.
in which 128 (60 %) were male and 72 (40 %) were Mean age was 58.58 years with standard deviation
female (Table I) with age ranging from 40 to 83 years ±11.56 SD. Minimum age was 40 years while maximum
were selected in which most patients (35%) were in the age was 83 years.
age ranging between 60 to 69 years (Table II). The gender distribution among 200 patients was
An informed written consent was obtained from analyzed as n= 128(60%) patients were males while
the patient. After enrollment in the study, detailed n=72(40%) patients were females. There were
history, visual acuity using Snellen’s visual acuity chart, n=113(56.5%) patients with PCO in the right eye while
slit lamp examination, IOP by Goldman applanation n=87(43.5%) patients had PCO in the left eye after
tonometer, direct and indirect ophthalmoscopy, and B cataract extraction with posterior chamber intraocular
Scan ultrasonography done in cases of dense PCO lens implantation.
carried out before YAG laser capsulotomy. The patients The pre Nd:YAG laser posterior capsulotomy ,
evaluated for inclusion criteria. Patients were properly visual acuity of the patients was 6/12 in n=26(13%)
educated about the procedure. patients, 6/18 in n= 37(18.5%) patients, 6/24 in
The patients were subjected to measurement of n=45(22.5%) patients, 6/36 in n=67(33.5%) patients,
visual acuity by standard Snellen’s acuity chart and 6/60 in n=13(6.5%) patients and visual acuity worse
intraocular pressure measurements in mm of Hg on than 6/60 in n=12(6%) patients.(Table III).
Goldman’s applanation tonometer every time by same The visual acquity after one week of Nd:YAG laser
person and on the same apparatus. Before treatment posterior capsulotomy ,was 6/6 in n=23 (11.5%)
1% tropicamide (Mydriacyl) eye drops were instilled patients,6/9 in n= 34 (17%) patients, 6/12 in n=67
to dilate the pupil and the cornea was anaesthetized (33.5%) patients, 6/18 in n=33 (16.5%) patients, 6/24 in
with topical application of 0.5% proparacaine n=21 (10.5%) patients, 6/36 in n=13 (6.5%) patients and
hydrochloride (Alcaine) eye drops. Q- Switched Nd: 6/60 in n=9 (4.5%) patients. (Table IV)
YAG laser (SYL9000 YAG laser system) was used with There was improvement in visual acuity of two
Abraham’s posterior capsulotomy lens to make a hole or more lines on Snellen’s chart following Nd:YAG laser
of 3-4mm in the posterior capsule using 1.5 to 5mJ per posterior capsulotomy in n=169(84.5%) patients
pulse. The energy and pulses were increased gradually whereas n=31 (15.5%) patients showed no
improvement.( Table V ) Table III: Pre Nd: YAG laser Visual Acuity (N=200)
The pre Nd: YAG laser posterior capsulotomy,
Pre YAG visual acuity No of Patients Percentage
intraocular pressure with Goldman applanation
tonometer of the patients was 6 -10 mmHg in n= 48 (24 6/12 26 13 %
%) patients, 11-15mmHg in n= 124 (62 %) patients, 16- 6/18 37 18.5 %
20 mmHg in n= 28(14%) patients and IOP more than 20 6/24 45 22.5 %
mmHg was zero. (Table VI), so all those patients were 6/36 67 33.5 %
included who were having pre treatment IOP between 6/60 13 6.5 %
6 and 20mmHg.
Worse than 6/60 12 6%
The results after one week of Nd: YAG laser
posterior capsulotomy,assessment of change in Total 200 100 %
intraocular pressure measured with Goldman Table IV: One week after Nd: YAG laser Visual acuity (N=200)
applanation tonometer showed no change in IOP in
n=104 (52 %),increase of 1-2 mmHg IOP in n=36(18%) Pre YAG visual acuity No of Patients Percentage
patients, 3-4 mmHg in n= 32 (16 %) patients, 5-6 mmHg 6/6 23 11.5%
in n= 10 ( 5%) patients, 7-8 mmHg in n= 8 (4%) patients, 6/9 34 17%
9-10 mmHg in n=6 (3%) patients and increase in IOP
6/12 67 33.5%
more than 10 mmHg in n= 4 ( 2%). (Table VII)
The above result shows that 52% of the patients 6/18 33 16.5%
showed no change in IOP after Nd: YAG laser posterior 6/24 21 10.5%
capsulotomy while the remaining 48% patients showed 6/36 13 6.5%
some degree of change in IOP after Nd: YAG laser 6/60 9 4.5%
posterior capsulotomy in which most of the increase Total 200 100 %
was in the range of 1-4 mm Hg in n=68(34%) patients
and only 14% of the patients showed increase in IOP Table V: Distribution of Post Nd: YAG laser visual acuity (N=200)
more than 5mmHg which needed special attention and
regular follow up for proper control of IOP. Post YAG laser visual acuity No of Patients Percentage
DISCUSSION: Improved 169 84.5%
In ophthalmology, Nd: YAG laser posterior Not improved 31 15.5%
capsulotomy is a routine procedure, since up to 40% of Total 200 100%
the patients submitted to cataract surgery with IOL
implantation develop posterior capsule opacification Table VI: Pre Nd: YAG laser IOP measurement (N=200)
despite the progress made in surgical techniques1,3.
Pre YAG laser IOP No of Patients Percentage
Although Nd: YAG laser is considered to be a safe
procedure, it can cause several complications, namely 0-5mmHg 0 0%
retinal detachment, iritis, macular edema, IOL cracks 6-10 mmHg 48 24%
and pits and IOP spike1, 2. In the present study we 11-15 mmHg 124 62%
16-20 mmHg 28 14%
Table 1I: Showing gender distribution (N=200) > 20 mmHg 0 0%
Total 200 100
Gender No of Patients % age
Male 128 60% Table VII: IOP after one week of Nd: YAG laser Capsulotomy (N=200)
Female 72 40%
Increase in IOP No of Patients Percentage
Total 200 100%
No change in IOP 104 52%
Table II: Age range of the respondents (N=200) 1-2 mmHg 36 18%
3-4 mmHg 32 16%
Age Frequency Percentage
5-6 mmHg 10 5%
40 to 49 years 48 24 %
7-8 mmHg 8 4%
50 to 59 years 50 25 %
9-10 mmHg 6 3%
60 to 69 years 70 35 %
> 10mm Hg 4 2%
e” 70 years 32 16 %
Total 200 100%
Total 200 100%
compare the change in IOP and visual acuity in patients and vitrectomy surgery. 12 A national study of
undergoing Nd: YAG laser for posterior capsule Hyderabad showed that there were no patients that had
opacification after extracapsular cataract extraction/ VA 6/6 – 6/12 pre-treatment but after treatment there
phacoemulcification and posterior chamber intraocular were 372 (74.4%) patients who had VA 6/6 – 6/12.19
lens implantation. Regarding the improvement in the final VA of two
There are 200 patients included in our study with or more lines on Snellen’s chart, 169(84.5% ) patients
mean age range of patients of 58.58 ±11.56 years. The showed improvement while only 31 (15.5%) patients
mean age of such patients in one international study had no improvement in this study. Similar results were
done in Manchester Eye hospital, UK was 75.2 years. 10 also found in a recently conducted study in LRH
The mean age of patients in one national study Peshawar, which showed similar improvements in 91%
conducted at PGMI/LRH Peshawar was 54.78 ±13.51 of patients whereas, 9% of patients showed no
years.11 improvement in the final visual acuity.1
According to our study the mean duration CONCLUSION:
between the cataract surgery and Nd: YAG laser In our study it is concluded that visual acuity in
posterior capsulotomy was found to be 2.143± 1.223 patients who had developed posterior capsular opacity
years. In an another study it was found that the duration after cataract extraction with posterior chamber
between the cataract surgery and Nd:YAG laser intraocular lens implantation is better after Nd: YAG
posterior capsulotomy was between 10 to 15 months.12 laser posterior capsulotomy than the visual acuity
The majority of the patients (46%) had posterior before treatment with Nd: YAG laser posterior
capsular opacification between 3 months to 12 months capsulotomy. Regarding the change in IOP after
post operatively.13 Nd:YAG laser posterior capsulotomy,104(52% )of the
Apple DJ has noted that the incidence of PCO up patients showed no change in IOP, 68 (34% ) patients
to 50% by two years post operatively, 14 while other showed 1-4 mmHg increase in IOP, while 28(14% )
authors have reported the incidence of PCO up to 43% patients showed increase more than 5mmHg rise in IOP
in five years duration after extra capsular cataract which needed special attention and regular follow up
extraction 15 and in study of 369 eyes noted the till IOP was controlled.
frequency of PCO in 1.6%, 12.3% and 26.5% after REFERENCES
cataract surgery in the duration of 1, 2 and 3 years 1. Karezewicz D, Pinikowska-Machoy E, Modrzeyewska M,
etal.Posterior capsular opacification as a complication of the
respectively 16. posterior chamber intraocular lens implantation. KlinOczna.
The pre Nd:YAG laser posterior capsulotomy, 2004; 106:19-22.
distant visual acuity of the patients was 6/12 in 2. Hayashi K, Hayashi H, Nakao F, etal.Correlation between
n=26(13%) patients,6/18 in n= 37(18.5%) patients, posterior capsular opacification and visual functions before
and after Nd-YAG laser posterior capsulotomy. Am J
6/24 in n=45(22.5%) patients, 6/36 in n=67(33.5%) Ophthalmol.2003; 136: 720-6.
patients, 6/60 in n=13(6.5%) patients and visual acuity 3. Kurosaka D, Kato K, Kurosaka H, et al.Elschnig pearl
worse than 6/60 in n=12(6%) patients while in an formation along Nd-YAG laser posterior capsulotomy
international study of Greece,2.9% patients had VA margin, long term follow up. J Cataract Refract Surg. 2002;
28: 1809-13.
between 20/32 and 20/60,20.6% patients had VA 4. Aslam TM, Denlin H, DhilonB.Use of Nd-YAG laser
20/40,14.7% had VA between 20/50 and 20/60,20.6% capsulotomy. SurvOphthalmol. 2003; 48: 594-612.
had VA 20/80 and 26.6% had VA 20/100.17 While in a 5. Baratz KH, Cook BE, Hodge DO. Probability of Nd-YAG laser
local national study,80.4 % of patients had pre Nd: YAG capsulotomy after cataract surgery in Olmsted country
Minnesota. Am J Ophthalmol.2001; 131: 161-6.
laser VA > 6/9, among them 52.4 % had VA better than 6. Polak M, Zasnowaski T, ZargorskiZ.Results of Nd-YAG laser
6/60.18 capsulotomy in posterior capsule opacification. Ann
In our study the post Nd:YAG laser posterior UnivMariac Curie Sklodowska.2002; 57: 357-63.
capsulotomy ,the distant visual acuity of the patients 7. Daniele AR.Performing the posterior capsulotomy.
Highlights of ophthalmology (letter).1989;17: 7-11.
was 6/6 in n=23 (11.5%) patients,6/9 in n= 34 (17%) 8. Seong GJ, Lee YG, Lee JH, etal.Effect of 0.2% bromonidine in
patients, 6/12 in n=67 (33.5%) patients, 6/18 in n=33 preventing intraocular pressure elevation after Nd-YAG laser
(16.5%) patients, 6/24 in n=21 (10.5%) patients, 6/36 in posterior capsulotomy. Ophthalmic Surg Laser.2000; 31: 308-
n=13 (6.5%) patients and 6/60 in n=9 (4.5%) patients. 14.
9. Rakafsky S, Koch DD, Faulkner JD, etal.Levobunolol 0.5%
The study of Greece showed that out of 34 patients only and timolol maleate 0.5% to prevent intraocular pressure
1(2.9%) had post treatment VA 20/80 while other elevations after Nd-YAG laser posterior capsulotomy. J
patients (85.3%) had VA better than 20/60 and Cataract Refract Surg. 1997; 23: 1075- 80.
concluded that Nd: YAG laser capsulotomy seems to 10. Aslam TM, Patton N. Methods of assessment of patients for
Nd: YAG laser capsulotomy that correlate with final
be a safe and effective procedure for eyes that have visualimprovement.BMCOphthalmol 2004; 4:13.
previously undergone combined phacoemulsification 11. Rahil N, Rehman R, Malik R. Visual outcome after the use of
Neodymium – Yttrium Garnet (YAG) application for years after extracapsular cataract extraction.J Cataract Refract
posterior capsular opacification. IntOphthalmol Update 2012; Surg 1999; 25: 246-50.
11(1):40-43. 16. Erie JC, Hardwig PW, Hodge DO. Effect of intra ocular lens
12. Georgalas I, Petrou P, Kalantzis G, Papaconstantinuo D et design on Neodymium: YAG laser capsulotomy rates. J
al.Nd:YAG laser capsulotomy for posterior capsule Cataract Refract Surg 1998; 24: 1239-42.
opacification after combined clear corneal 17. Yeo KT, Lim ASM, Ling SL. Mass screening for diabetic
Phacoemulsification and vitrectomy.Therapeutics and retinopathy in the prevention of blindness. Asia Pacific J
Clinical Risk Management 2009;5:133-7. Ophthalmol 1995; 7:2-10.
13. Khanzada MA, Jatoi SM, Nasrani AK, Dabir SA, Gul S. 18. Kayani H, Rehan N, Ullah N. Frequency of retinopathy
Experience of Nd: YAG laser posterior capsulotomy in 500 among diabetic s admitted in a teaching hospital of Lahore.
cases. J LiaqatUni Med Health Sci 2007; 6: 109-15. J Ayub Med Coll Abbottabad 2003; 15(4):53-6.
14. Apple DJ, Solomon KD, Tetz MR. Posterior capsule 19. Kohner EN, Porta M. Screening for Diabetic Retinopathy in
opacification.SurvOphthalmol 1992; 37:73-116. Europe: A Field Guide Book. Copenhagen: WHO Regional
15. Sundelin K, Sjostrand J. Posterior capsule opacification 5 office for Europe, 1992.
ABSTRACT
Objective: The objective of this study was to review the current ophthalmic literature regarding the applications of
femtosecond laser in the field of ophthalmology.
Study Design:Literature Review.
Setting: Eye Unit-I, B.V. Hospital, Bahawalpur; Pakistan.
Results: Femtosecond lasers offer the ophthalmologist an ability to cut the tissues at various depths, with different
patterns and minimal collateral tissue injury. This technology has dramatically changed the corneal refractive surgery and
is anticipated to do the same for the cataract surgery as well. The companies i.e. the IntraLase, the FEMTEC, the
OptiMedica, the LenSx and the LensAR have developed their femtosecond laser systems to be used for different ophthalmic
surgical procedures. These systems can perform the corneal incisions, the capsulotomy, and the lens fragmentation.
Conclusion:Femtosecond laser provides a more precise and safer approach towards ocular surgery.
Key Words: Cataract surgery; corneal refractive surgery; Femtosecond laser
subsequently leads to a better visual outcome. capsulorrhexis of <5.5mm has been shown to cause
Femtosecond laser works essentially by anterior capsular phimosis and postoperative hyperopic
vaporizing the targeted tissues through the formation shift18. At the same time, a too large capsulorrhexis leads
of plasma and micro-cavitation bubbles. These lasers to insufficient overlap of the intraocular lens by the
became available for the first time in 2001. Initial capsule thus increasing the incidence of postoperative
application of the femtosecond laser was limited to the lens tilt, decentration and posterior capsular
creation of corneal flaps during Laser Assisted In-situ opacification, sometimes needing a lens exchange19-21.
Keratomileusis (LASIK) 11,12 . Flaps created by Creating a precise and predictable capsulotomy should
femtosecond laser were observed to be reproducible, reduce the incidence of aforementioned complications
uniform, well centered and closer to their intended (Fig. 2) The construction of a capsulotomy is also
thickness when compared to the flaps created manually important in estimating the effective lens position (ELP).
with the help of a microkeratome. Since then, use of ELP is a value derived from empirical data of the A-
femtosecond lasers has been expanded to other constant and the surgeon’s factor.
procedures including customized trephination The size of the capsulorrhexis has a direct relation
penetrating keratoplasty (PKP), anterior/posterior with the ELP28. Inappropriate estimation of the ELP is
lamellar keratoplasty, tunnel creation for intracorneal the biggest source of error in intraocular lens power
ring segements, astigmatic keratotomy. Most recently, calculation29. A difference of 1mm in ELP can lead to a
femtosecond laser has been applied to cataract surgery. refractive error of about 1.25 diopters18,30,31. For toric and
Femtosecond laser-assisted cataract surgery: multifocal intraocular lenses, the window for error is
Cataract surgery is the most commonly performed even smaller. Tilt, decentration or rotation of these
ocular procedure throughout the world14. Approxi- lenses in-situ can cause significant optical aberrations
mately 3 million cataract surgeries were performed in including halos and coma effect which are extremely
the USA during the year 2006 and this number will difficult to tolerate 21,32,33. With current technology, no
continue to grow as the population ages. The eye disease tools exist to guide perfect centration of the
prevalence research group in 2004 estimated that 20.5 capsulotomy/capsulorrhexis except the anatomical
million Americans and 30.1 million Americans by 2020, landmarks e.g. the borders of a dilated pupil or the
will have catarct15. Until recently, the primary outcome limbal edge, making the patients having irregularly
of cataract surgery has been functional vision of 20/40 dilated pupils or corneal haze challenging in this
or better with accuracy of +1 diopter. However, with respect. Predictable and controlled positioning of the
current biometry and surgical methods, studies report intraocular lens can be achieved more often when the
that only 45% of the patients are within 0.5 diopters of capsulorrhexis size incision is perfectly sized and
their targeted postoperative refraction, and 6% have precisely centered. This is possible through the use of
more than 2 diopters of residual refractive error 17. With femtosecond lasers (Fig. 3).
the advent of multifocal and accommodative intraocular Femtosecond Laser-Assisted Lens Fragmenta-
lenses, more and more patients are opting for earlier tion: Femtosecond lasers can be used to fragment the
cataract surgery with less tolerance for visual crystalline lens nucleus. This allows the operating
impairment. At the same time ophthalmologists are surgeon to skip the difficult steps of phaco-
facing increasingly high patient expectations for emulsification i.e. the sculpting/ chopping which is a
postoperative refractive outcome. Today, the goal of common source of complications during surgery34-36.
cataract surgery is to achieve near emmetropia. For this Additionally, patterns of cuts can be placed on the
reason, femtosecond lasers can improve the results of nucleus in order to soften a harder cataract (Fig. 4).
cataract surgery due to remarkable reproducibility, These maneuvers are a means to reduce the need for
centration, and safety during cataract surgery. To date, ultrasound energy from the phaco-tip thereby
the femtosecond laser systems are engineered to minimizing the risk of capsular complications and
perform four groups of incisions i.e. the capsulotomy, corneal endothelial injury37-39. There is an added safety
the lens fragmentation, the limbal relaxing incisions and benefit of reducing the unnecessary instrumentation
the clear corneal incisions. and manipulation of the crystalline lens during surgery.
Femtosecond laser-assisted capsulorrhexis:Use Finally, the femtosecond laser treatments may be
of femtosecond lasers for capsulotomy or laser assisted optimized for the irrigation/aspiration phaco-dynamics
capsulorrhexis (Fig. 1) has the potential to revolutionize to reduce the aspiration flow rate (AFR) and the
the cataract surgery. Studies show that the size of the intraoperative iris prolapse.
capsulorrhexis is of immense importance for an optimal Steps in Femtosecond Laser-Assisted Cataract
lens positioning and intraocular lens performance. With Surgery: There are four primary steps of femtosecond
single-piece aspheric intraocular lens, a small laser assisted cataract surgery i.e. the planning, the
engagement, the visualization, customization and the above-mentioned complications and also prevents
treatment. Two sub-systems that are of critical corneal folds that occur with suction ring. This allows
importance during laser assisted cataract surgery for a precise laser focus, thus, minimizing the energy,
include the docking system (for engagement step) and reducing the cavitation bubble formation and
the image guidance system (for visualization and optimizing the treatment results.
customization steps). The approach towards these steps All the three systems i.e. the OptiMedica, the
is slightly variable between the LenSx, the LensAR, and LenSx and the LensAR have proved to be effective in
the OptiMedica laser systems. Some of the salient stabilizing the globe and minimizing the risk of
features are discussed here. intraocular pressure spikes during the surgery.
A-The Planning: Before embarking upon cataract However the method and device for docking appears
surgery, the individual variations in pupil size, the lens to be different for each laser platform. OptiMedica
thickness, the corneal thickness are to be measured. employs liquid optics interface which causes a pressure
After initial planning, adjustments are made in real-time rise of only 8-12mmHg and has good stabilization of
by using drag and drop interface with incisional the globe during the engagement step. LenSx has a
overlays on video as well as cross sectional images.For curved lens and suction system. LensAR has a non-
performing the capsulorrhexis, the planning parameters contact, non-applanating water-bath suction and
include the size, the shape and the required centration fixation device49.
of the incision. Primary driver for the capsulotomy C-The Visualization and Customization: The
planning is the intraocular lens. image guidance system is a critical part of femtosecond
For performing the lens fragmentation, the assisted cataract surgery as it determines the location
parameters of importance are the depth, the pattern and and dimensions of the ocular structures i.e. the cornea,
the diameter of the cuts. These are indirectly dependent the iris and the crystalline lens capsule. This system
upon the density and thickness of the cataract. These allows the operating ophthalmologist to customize the
parameters can be matched to the surgeon’s preferred zones for placement of laser assisted incisions and lens
technique of surgery and thus reduce the phaco time fragmentation. The corneal thickness should be
and energy.For performing the limbal relaxing incisions determined so that the architecture of relaxing and
(LRIs), traditional nomograms are used for planning. surgical incisions can be properly customized for each
However, as the effect of pneumo-dissection from patient. The system used must be able to detect the iris
cavitation bubbles is quantified. For clear corneal boundaries in order to safely direct the laser within even
incisions (CCIs), the planning parameters include the the asymmetrically dilated pupil. They must also
location, the depth and the architecture of incision. generate a reference for the size and centration of the
B-The Engagement: Prior to delivering the laser, capsulorrhexis/capsulotomy. It is also critical to detect
it is necessary to stabilize the patient’s eye relative to the posterior surface of crystalline lens in order to
the optical system of the laser. During refractive surgery maintain a safety zone, preventing any inadvertent cuts
it is accomplished through the use of a suction ring in the posterior lens capsule.
which causes distortion of the globe. Studies comparing The LenSx and the OptiMedica use Fourier-
the real-time changes in intraocular pressure during this Domain Optical Cohorence Tomography (FD-OCT) for
maneuver between femtosecond assisted surgery three dimensional viewing of ocular structures. This
versus mechanical keratome assisted surgery have allows for real-time, high resolution measurements of
shown that the IntraLase interface (Abbot Medical the corneal thickness, the lens position, the iris
Optics, California, USA) can cause a rise of about boundaries and the irido-corneal angle49-52. The LensAR
90mmHg while the VisuMax interface (Carl-Zeiss uses a three dimensional confocal illumination-scanning
Meditec, California, USA) causes a rise of 82mmHg in transmitter, a technology similar to Schiempflug camera
intraocular pressure47,48. Altohough this much amount system49. Schiempflug camera systems are capable of
of pressure rise is well tolerated during refractive determining corneal power elevation maps, the anterior
surgery, the elderly patients having cataract and chamber depth and the corneal wave-front analysis53,54.
coexisting glaucoma or other ocular comorbidity have The lens density can also be evaluated and quantified,
an increased risk of retinal nerve fibre layer damage allowing lens fragmentation settings to be selected
due to transient ischemia of the retinal tissues during automatically55. A preview of the software for each
the engagement process. An ideal interface would be system indicates that size of safety zones vary among
one which stabilizes the globe without causing any each system to ensure that the laser energy does not
distortion of the eye or an increase in intraocular adversely affect the ocular structures (Fig. 6).
pressure. The interface employing a liquid cushion D-The Treatment: This is the final step of the laser
between the eye and the laser system minimizes the assisted cataract surgery. The laser spot pattern for a
single incision is applied from posterior to anterior. This to the manual (Fig. 6). To date, LensAR has not reported
maneuver maintains precise focus, avoiding scatter of on centration of the intraocular lens.
the laser beam and also reduces the amount of Studies are still underway to optimize the
radiations reaching the retina72. available patterns of lens fragmentation for each
The three systems differ in the order of incision commercial system56,63. To assess the efficacy of laser
delivery. The OptiMedica offers the capsulotomy/ assisted lens fragmentation, all the three companies
capsulorrhexis first and then the lens fragmentation. looked at the ultrasound energy output of the
This sequence of events reduces the risk of a capsular phacoemulsification in lenses treated with laser or not
tear or zonular dehiscence because the lens is allowed and showed a marked reduction in ultrasound energy
to relax as it is fragmented. In the LenSx system, initially for all grades of cataracts. The percentage of energy
the nucleus is fragmented and the capsulorrhexis is reduction was variable among the three laser systems
performed afterwards56. but was 33% atleast.62,63,64
Clinical Outcomes of the Femtosecond Laser- Femtosecond Laser-Assisted Limbal Relaxing
Assisted Cataract Surgery: Incisions (iris): Femtosecond laser systems can perform
Nagy et al first published the results of cataract corneal or limbal relaxing incisions (LRIs) to correct
surgery using the LenSx femtosecond laser system in up to 3.5 diopters of astigmatism. The laser causes
2009. They compared the manual capsulorrhexis to laser flattening of the steeper meridian of the cornea thus
assisted capsulorrhexis in porcine eyes on the basis of eliminating the source of refractive error40. However at
reproducibility and maximum resistance to stretching. present, only a small number of patients are undergoing
Their results showed that the laser assisted manual limbal relaxing incisions. This is because the
capsulotomies were much more reproducible, uniform manual incisions are technically demanding and have
and precisely placed 57 . Scanning laser electron unpredictable results. Inconsistency in the outcomes of
microscopy revealed that the edges of such manual limbal relaxing incisions is often related to
capsulotomies were smooth and the strength of the discrepancies in depth, axis, arc length and optic zone
rhexis edge could tolerate a higher stretching force of the incision. It has been stated that an axis
before rupture. They also showed that the lens misalignment of just 50 results in 17% reduction in
fragmentation via femtosecond laser led to a 43% effect40. These problems have been solved by the advent
reduction in phaco power and a 51% reduction in time. of femtosecond lasers. The superior accuracy afforded
The corneal edema and the anterior chamber activity by this laser over manual procedures could lead to an
were mild in laser treated eyes during the first improvement in outcomes of limbal relaxing incisions.
postoperative day and these findings resolved Femtosecond Laser-Assisted Clear Corneal
completely by first week post surgery57. Although the Incisions (CCIS):The self-sealing clear corneal incision
study employed only a limited number of patients, yet is now the preferred method of entry into anterior
the femtosecond laser assisted cataract surgery chamber of the eye. Recent studies report that about
appeared to be well tolerated for use in this study. 75% of the cataract surgeons in the USA are using the
OptiMedica59,62 reported capsulotomy diameters clear corneal incision during cataract surgery in an order
within 27 microns (SD, 25microns) of the intended to achieve a superior visual outcome and faster visual
diameter (Fig. 5). This is compared with 183 microns recovery41,42. The drawbacks of the manually created
(SD, 246microns) for LensAR60. LenSx reported that all clear corneal incisions include an increased incidence
capsulotomies were within 250microns of the intended of postoperative endophthalmitis 43, gaping at the
diameter61. All the three companies found that the laser internal aspect of the wound and a risk of Descmet’s
capsulotomies were more precise than manual membrane detachment44. Femtosecond laser assisted
capsulorrhexes with OptiMedica59 reporting manual clear corneal incisions show less features of damage and
results at 339microns (SD, 248microns), and the LensAR faster healing rate. This may be due to special properties
reporting nearly 500microns for manual of such wounds or from reduction in the mechanical
capsulorrhexes60. For the capsulotomy, each company stresses during the operation45,46.
used different measurement techniques, a direct Femtosecond Laser-Assisted Penetrating
comparison of the three companies is not easily Keratoplasty (PKP):Earlier investigations involving
assessed. femtosecond laser for penetrating keratoplasty incisions
For capsulotomy position, OptiMedica reported revealed that a “top-hat” shaped incision led to better
the intraocular lens centration within 86microns (SD, wound stability with seven-fold increased resistance to
51microns) of the intended placement59. The LenSx leakage and a possible decrease in risk of postoperative
reported intraocular lens centration was significantly astigmatism when compared to wounds created
better (p=0.027) in laser assisted group61 as compared through conventional trephination72,73. In subsequent
studies on femtosecond laser assisted corneal incisions, healing rate and astigmatism control was
a variety of other wound configurations were identified. superior with femtosecond laser assisted top-hat
These include the “mushroom”, the “zigzag” and the incision when compared to manual top-hat incision.
“Christmas tree” shapes (Fig. 7C-E). From a mechanical Results of the studies conducted by Burrato and Bohm75
strength stand point, all of these wound configurations were also in line with findings of the above mentioned
create more stable wound when compared to the researchers.Femtosecond assisted zigzag incision when
traditional “butt” joint (Fig. 7A) created through compared to conventional trephination incision, had a
standard corneal trephination. Optical distortion and more rapid visual recovery and less induced
poor visual outcome following penetrating keratoplasty astigmatism83. There was a significant difference in
are often a result of misalignment of the donor-host average astigmatism between the two groups at
cornea, rotational misalignment, uneven suture tension postoperative month 1 and 3 (3D in laser assisted
and postoperative slow and uneven wound healing. The incision versus 4.46D in conventional incision). Also,
goal of femtosecond laser assisted corneal incision the number of patients achieving the visual acuity of
during penetrating keratoplasty is the creation of a 20/40 at three months was statistically higher (p<0.03)
structurally stable and predictable wound configuration in laser assisted group when compared to the manual
with the objective of rapid visual rehabilitation and trephination group (81% versus 45%).
higher optical quality compared with conventional The mechanism thought to be responsible for
blade assisted trephination. higher success rate of laser assisted incisions is the
Earlier results of outcomes with the femtosecond angled edge of the zigzag cuts, which provides a smooth
laser assisted keratoplasty show better alignment of the anterior transition between the host-donor interfaces,
donor-host surface. Improved sealing of the incision leading to hermetic wound healing. This improved
permits the ophthalmologist to use only optimal suture natural alignment intrinsically produces less optical
tension to keep the incision opposed without undue distortion, watertight seal and less suture tension and
distortion of the cornea. In addition, increased surface resultant lesser amounts of astigmatism. Alternatively,
area of these incisions leads to increased tensile strength there is rapid recovery of wound edema in femtosecond
of the wound, improving both patient safety and group due to less tissue manipulation and trauma as
allowance of an earlier suture removal (Fig. 8). This in compared to conventional trephination83.
turn leads to a rapid visual recovery and lesser The top-hat and the zigzag incisions are the two
astigmatism than traditional blade assisted most popular femtosecond laser assisted incisions due
keratoplasty74-78. to their enhanced accuracy over conventional incisions.
The first femtosedcond laser platform to For the same reason, from a biomechanical stand point,
accomplish the full thickness cuts was the IntraLase the zigzag cuts may prove to be the most stable74. This
(IntraLase Femtosecond Laser, Irvine, California, USA). type of incision allows for consistent suture placement
With the use of this platform, penetrating keratoplasty at about 50% of stromal depth at the position where
is now better known as IntraLase Enabled Keratoplasty the posterior cuts and the lamellar incisions intersect.
(IEK). With top-hat incision, suture placement may vary
FEMTEC (20/10 perfect vision, Heidelberg, leading to a possibility of posterior wound gape with a
Germany) is the second platform by which stable full negative impact on postoperative visual outcome.
thickness keratoplasty can be performed. Preliminary Recently, software has been developed allowing
studies performed on this system demonstrate that the application of radial alignment marks on the donor/
short time visual results of this system are analogous host cornea. This helps more precise suture placement
to other femtosecond assisted penetrating keratoplasty with an improved tissue distribution and a tendency
systems.Price et al76 through their study demonstrated towards lesser astigmatism in eyes undergoing
that the endothelial cell loss at one year after femtosecond assisted keratoplasty. Another technique
femtosecond laser assisted keratoplasty was analogous to the radial alignment marks is the
comparable to that in conventional keratoplasty. A application of orientation teeth. This technique showed
rapid wound healing rate was observed in this study low-moderate astigmatism postoperatively84.
with mean time for suture removal of seven months. Femtosecond Laser-Assisted Deep Anterior
Hoffartet al82 used the FEMTEC laser and showed that Lamellar Keratoplasty (Dalk):The femtosecond laser
the visual and refractive outcome of this system was technology is recently being expanded to aid in other
comparable to the other laser systems. It is also worth corneal transplantation techniques. Deep Anterior
mentioning that the FEMTEC system currently allows Lamellar Keratoplasty (DALK) with ‘big-bubble’
only the straight cuts. Bahar et al78 used the IntraLase technique is now preferred procedure for anterior
system and showed that the visual outcome, wound corneal disease. This technique has been employed
Figure 1: Laser capsulotomy. Figure 2: Intraocular lens as seen through the laser capsulotomy.
View of an accurately sized and precisely shaped laser Slit-lamp view of a laser capsulotomy having uniform overlap of
capsulotomy seen through the catalys tm precision laser system. the intraocular lens optic.
successfully for treating the keratoconus as well as for originally by Anwar et al requires a 60-80% trephination
the management of anterior stromal pathology in cases followed by intracameral injection of air and lamellar
having a healthy endothelium. Anwar et al85 applied dissection of the anterior stroma manually in order to
big-bubble technique for baring of descemet’s identify and reach the posterior stroma. Posterior
membrane during maximum depth anterior lamellar stroma is then excised carefully over a blunt iris spatula
keratoplasty in patients having keratoconus. In a series in order to protect the Descmet’s membrane from the
of 181 eyes which underwent this procedure, 89% sharp tip 85 . The newer technique employing
achieved visual acuity of 20/40 or better. femtosecond laser avoids the manual trephination and
Big-bubble technique DALK has several allows precise identification of tissue depth and
advantages over conventional penetrating keratoplasty. injection of air by following a plane between the lamellar
These include the safety of extraocular procedure, low and posterior side cuts of the zigzag wound92,93. Injection
risk of endothelial rejection and a shorter course of of a big-bubble at this depth facilitates full baring of
postoperative corticosteroid use91. the Descmet’s membrane.
The big-bubble DALK technique described The femtosecond DALK procedure has also been
used successfully using mushroom shaped incision94. of femtosecond laser. Additionally the femtosecond
The reference radial incision marks created by the laser laser treated eyes had a greater incidence of endothelial
allow precise suturing of the tissue to optimize cell loss when compared to the eyes undergoing
postoperative astigmatism and minimize the corneal conventional keratoplasty95. Studies are ongoing to look
distortion. at the energy level and the spot size patterns of the
Penetrating keratoplasty for ectatic corneal femtosecond laser in order to minimize interface haze
conditions is traditionally known to have the most and distortions. This may improve the results of the
success rate in terms of visual recovery and healing. FLEK in near future.
However, as these patients are usually younger, the risk Future Prospects of Femtosecond Lasers in
of endothelial graft rejection is higher. The ideal Ophthalmology:Ultrasound Biomicroscopy (UBM)
procedure in such patients would be one that can images of the normal accommodation in young eyes
maintain patient’s own endothelium and replaces only demonstrates that predominant effect on intact lens is
the diseased part of the stroma along with a superior at the level of the anterior capsule62. Laser assisted
wound approximation and minimal induced cataract surgery, with its improved precision and
astigmatism. The femtosecond laser assisted custom accuracy, may allow a better preservation of the
shaped cuts combined with the big-bubble DALK biomechanical properties of the lens capsule, enabling
technique successfully achieves this goal. This method the creation of better accommodative intraocular lenses.
also preserves the option to perform a full thickness Some studies are also investigating the femtosecond
penetrating keratoplasty with the benefits of lasers to restore accommodation in presbyopic eyes by
femtosecond laser incision if the dissection of Descmet’s increasing the flexibility of the lens either by separating
membrane fails during the surgery. the collagen fibrils, or by applying the laser assisted
Femtosecond Laser-Assisted Endothelial incisions that act as gliding planes65,66-68.
Keratoplasty (FLEK): Use of femtosecond lasers for Other applicatons of the femtosecond lasers are
endothelial keratoplasty (FLEK) has yielded mixed being evaluated, expanding the patient population for
results 94,95. Cheng et al performed a randomized which cataract surgery and lens exchange procedures
controlled trial on a group of 80 eyes comparing are possible. Lee et al69 described a technique by which
femtosecond laser endothelial keratoplasty (FLEK) to they created a flap to remove the corneal opacities,
conventional keratoplasty (PKP) and found that the allowing better visualization of a cataractous lens and
patients undergoing femtosecond laser assisted surgery greater ease of maneuvering the difficult cases.
had a significantly lower postoperative astigmatism. At Nishimotoet al 70 describe using an intentionally
the same time it was also observed by the researchers decentered intraocular lens for managing the cases
that the best corrected visual acuity was significantly having vertical diplopia.
lower in group treated with laser assisted keratoplasty. There are a group of investigators which is
This finding may be due to interface haze resulting from attempting to use the femtosecond laser to reverse some
roughened collagen fibrils produced by the application of the accumulated damages which lead to cataract and
presbyopia. Keesel et al have recently shown that the United States. Arch Ophthalmol2004; 122:487–494.
senile yellowing of the crystalline lens can be reduced 16. Gale RP, Saldana M, Johnston RL, et al. Benchmark standards
for refractive outcomes after NHS cataract surgery. Eye
by femtosecond laser assisted photolysis71. (Lond) 2009; 23:149–152.
CONCLUSION: 17. Murphy C, Tuft SJ, Minassian DC. Refractive error and visual
The future of the cataract surgery may be the outcome after cataract extraction. J Cataract Refract
treatment options that allow the lens to be extracted Surg.2002; 28:62–66.
18. Sanders DR, Higginbotham RW, Opatowsky IE, Confino J.
within a wholly intact capsule which could then be Hyperopic shift in refraction associated with implantation
replaced with an injectable polymer. It may be that the of the single-piece Collamer intraocular lens. J Cataract
natural crystalline lens can have its optical properties Refract Surg.2006; 32:2110–2112.
restored with femtosecond laser modifications. 19. Wallace RB 3rd. Capsulotomy diameter mark. J Cataract
Refract Surg.2003; 29:1866–1868.
Throughout all these applications, the new femtosecond 20. Ravalico G, Tognetto D, Palomba M, et al. Capsulorhexis size
laser systems can emerge in the near future and bring and posterior capsule opacification. J Cataract Refract Surg
the practicing ophthalmologist one step closer to an 1996; 22:98–103.
ideal surgery that corrects cataract, astigmatism and 21. Walkow T, Anders N, Pham DT, Wollensak J. Causes of
severe decentration and subluxation of intraocular lenses.
presbyopia all in single step. Graefes Arch ClinExp Ophthalmol1998; 236:9–12.
REFERENCES: 22. McLeod SD, Vargas LG, Portney V, Ting A. Synchrony dual-
1. Krasnov MM. Laser-phakopuncture in the treatment of soft optic accommodating intraocular lens. Part 1: Optical and
cataracts. Br J Ophthalmol.1975;59:96–8. biomechanical principles and design considerations. J
2. Dodick JM, Pahlavi IA. Lasers in small-incision cataract Cataract Refract Surg 2007; 33:37–46.
surgery. In: Fankhauser F, Kwasniewska S, editors. Lasers in 23. Ossma IL, Galvis A, Vargas LG, et al. Synchrony dual-optic
ophthalmology: basic diagnostic and surgical aspects. accommodating intraocular lens. Part 2: Pilot clinical
Amsterdam, the Netherlands: Kugler Publications; 2003. pp. evaluation. J Cataract Refract Surg.2007; 33:47–52.
395–402. 24. Vargas LG, Auffarth GU, Becker KA, et al. Performance of
3. Fankhauser F, Roussel P, Steffen J, et al. Clinical studies on the 1CU accommodating intraocular lens in relation to
the efficiency of high power laser radiation upon some capsulorhexis size. J Cataract Refract Surg.2005; 31:363–368.
structures of the anterior segment of the eye. First experiences 25. Sacu S, Findl O, Menapace R, Buehl W. Influence of optic
of the treatment of some pathological conditions of the edge design, optic material, and haptic design on capsular
anterior segment of the human eye by means of a Q-switched bend configuration. J Cataract Refract Surg.2005; 31:1888–
laser system. Int Ophthalmol.1981; 3:129–139. 1894.
4. Aron-Rosa D, Aron JJ, Griesemann M, Thyzel R. Use of the 26. Park TK, Chung SK, Baek NH. Changes in the area of the
neodymium-YAG laser to open the posterior capsule after anterior capsule opening after intraocular lens implantation.
lens implant surgery: a preliminary report. J Am Intraocul J Cataract Refract Surg 2002; 28:1613–1617.
Implant Soc.1980; 6:352–354. 27. Gonvers M, Sickenberg M, van Melle G. Change in
5. Aron-Rosa DS, Aron JJ. Effect of preoperative YAG laser capsulorhexis size after implantation of three types of
anterior capsulotomy on the incidence of posterior capsule intraocular lenses. J Cataract Refract Surg1997; 23:231–238.
opacification: ten year follow-up. J Cataract Refract 28. Cekic O, Batman C. The relationship between capsulorhexis
Surg.1992; 18:559–561. size and anterior chamber depth relation. Ophthalmic Surg
6. PeymanGA, Katoh N. Effects of an erbium: YAG laser on Lasers.1999; 30:185–190.
ocular structures. IntOphthalmol 1987; 10:245–253. 29. Norrby S. Sources of error in intraocular lens power
7. Dodick JM. Laser phacolysis of the human cataractous lens. calculation. J Cataract Refract Surg 2008; 34:368–376.
Dev Ophthalmol1991; 22:58–64. 30. Lakshminarayanan V, Enoch JM, Raasch T, et al. Refractive
8. Seibel BS. Phacodynamics: mastering the tools and techniques changes induced by intraocular lens tilt and longitudinal
of phacoemulsification surgery. 4th ed. Thorofare, New displacement. Arch Ophthalmol.1986;104:90–92.
Jersey: SLACK Incorporated; 2005. 31. Erickson P. Effects of intraocular lens position errors on
9. Kanellopoulos AJ. Laser cataract surgery: a prospective postoperative refractive error. J Cataract Refract Surg 1990;
clinical evaluation of 1000 consecutive laser cataract 16:305–311.
procedures using the Dodick photolysis Nd:YAG system. 32. Baumeister M, Buhren J, Kohnen T. Tilt and decentration of
Ophthalmology 2001; 108:649–654; discussion 654–655. spherical and aspheric intraocular lenses: effect on higher-
10. Sugar A. Ultrafast (femtosecond) laser refractive surgery. order aberrations. J Cataract Refract Surg 2009; 35:1006–1012.
CurrOpin Ophthalmol2002; 13:246 249. 33. Buckhurst PJ, Wolffsohn JS, Naroo SA, Davies LN. Rotational
11. Nordan LT, Slade SG, Baker RN, et al. Femtosecond laser and centration stability of an aspheric intraocular lens with
flap creation for laser in situ keratomileusis: six-month a simulated toric design. J Cataract Refract Surg.2010;
follow-up of initial U.S. clinical series. J Refract Surg.2003; 36:1523–1528.
19:8–14. 34. Artzen D, Lundstrom M, Behndig A, et al. Capsule
12. Salomao MQ, Wilson SE. Femtosecond laser in laser in situ complication during cataract surgery: case-control study of
keratomileusis. J Cataract Refract Surg 2010; 36:1024–1032. preoperative and intraoperative risk factors – Swedish
13. Farid M, Steinert RF. Femtosecond laser-assisted corneal Capsule Rupture Study Group report 2. J Cataract Refract
surgery. CurrOpinOphthalmol 2010; 21:288–292. Surg 2009; 35:1688–1693.
14. Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in 35. Gauba V, Tsangaris P, Tossounis C, et al. Human reliability
the United States, 2006. Natl Health Stat Report 2009; (11):1– analysis of cataract surgery. Arch Ophthalmol 2008; 126:173–
25. 177.
15. Congdon N, Vingerling JR, Klein BE, et al. Prevalence of 36. Bellini LP, Brum GS, Grossi RS, Borowsky C. Cataract surgery
cataract and pseudophakia/aphakia among adults in the complication rates. Ophthalmology 2008; 115:1432; author
73. Steinert RF, Ignacio TS, Sarayba MA.”Top hat”-shaped penetrating keratoplasty. Am J Ophthalmol.2008 Jul;
penetrating keratoplasty using the femtosecond laser. Am J 146(1):46-49.
Ophthalmol.2007 Apr; 143(4):689-91. 85. Anwar M, Teichmann KD. Deep lamellar keratoplasty:
74. Farid M, Kim M, Steinert RF. Results of penetrating surgical techniques for anterior lamellar keratoplasty with
keratoplasty performed with a femtosecond laser zigzag and without baring of Descemet’s membrane.
incision initial report. Ophthalmology.2007 Dec; Cornea.2002 May;21(4):374-83.
114(12):2208-12. 86. Tan DT, Parthasarathy A. Deep anterior lamellar keratoplasty
75. Buratto L, Böhm E. The use of the femtosecond laser in for keratoconus. Cornea.2007 Sep; 26(8):1025; author
penetrating keratoplasty. Am J Ophthalmol. 2007 reply 1025-6.
May;143(5):737-742. Epub 2007 Mar 19. 87. Park KA, Ki CS, Chung ES, et al. Deep anterior lamellar
76. Price FW Jr, Price MO. Femtosecond laser shaped penetrating keratoplasty in Korean patients with Avellino dystrophy.
keratoplasty: one-year results utilizing a top-hat Cornea.2007 Oct; 26(9):1132-5.
configuration. Am J Ophthalmol.2008 Feb;145(2):210-214. 88. Parthasarathy A, Tan DT. Deep lamellar keratoplasty for
77. Cheng YY, Tahzib NG, van Rij G, et al. Femtosecond laser- acanthamoeba keratitis. Cornea.2007 Sep; 26(8):1021-3
assisted inverted mushroom keratoplasty. Cornea.2008 Jul; 89. Villarrubia A, Pérez-Santonja JJ, Palacín E, et al. Deep anterior
27(6):679-85. lamellar keratoplasty in post-laser in situ
78. Bahar I, Kaiserman I, Lange AP, et al. Femtosecond laser keratomileusiskeratectasia. J Cataract Refract Surg. 2007 May;
versus manual dissection for top hat penetrating keratoplasty. 33(5):773-8.
Br J Ophthalmol.2009 Jan; 93(1):73-8. 90. Colin J, Velou S. Current surgical options for keratoconus. J
79. Seitz B, Brünner H, Viestenz A, et al.Inverse mushroom- Cataract Refract Surg.2003 Feb; 29(2):379-86.
shaped nonmechanical penetrating keratoplasty using a 91. Farid M, Steinert RF. Deep anterior lamellar keratoplasty
femtosecond laser. Am J Ophthalmol.2005 May; 139(5):941- performed with the femtosecond laser zigzag incision for the
4. treatment of stromal corneal pathology and ectatic disease. J
80. Meltendorf C, Schroeter J, Bug R, et al. Corneal trephination Cataract Refract Surg. 2009 May; 35(5):809-13.
with the femtosecond laser. Cornea.2006 Oct; 25(9):1090-2. 92. Price FW Jr, Price MO, Grandin JC, et al. Deep anterior
81. Holzer MP, Rabsilber TM, Auffarth GU. Penetrating lamellar keratoplasty with femtosecond-laser zigzag
keratoplasty using femtosecond laser. Am J incisions. J Cataract Refract Surg. 2009 May; 35(5):804-8.
Ophthalmol.2007 Mar; 143(3):524-6. 93. Chan CC, Ritenour RJ, Kumar NL, et al. Femtosecond laser-
82. Hoffart L, Proust H, Matonti F, et al. Short-term results of assisted mushroom configuration deep anterior lamellar
penetrating keratoplasty performed with the Femtec keratoplasty. Cornea.2010 Mar; 29(3):290-5.
femtosecond laser. Am J Ophthalmol.2008 Jul;146(1):50-55 94. Cheng YY, Schouten JS, Tahzib NG, et al. Efficacy and safety
83. Farid M, Steinert RF, Gaster RN, et al. Comparison of of femtosecond laser-assisted corneal endothelial
penetrating keratoplasty performed with a femtosecond laser keratoplasty: a randomized multicenter clinical trial.
zig-zag incision versus conventional blade trephination. Transplantation.2009 Dec 15; 88(11):1294-302.
Ophthalmology.2009 Sep; 116(9):1638-43. 95. Cheng YY, Hendrikse F, Pels E, et al. Preliminary results of
84. Mastropasqua L, Nubile M, Lanzini M, et al. Orientation teeth femtosecond laser-assisted descemet stripping endothelial
in nonmechanical femtosecond laser corneal trephination for keratoplasty. Arch Ophthalmol.2008 Oct; 126(10):1351-6.
Vitreous Cyst
Dr. Naveed Ahmad Qureshi
Assistant Professor, Al-Shifa Trust Eye Hospital, Rawalpindi
Treatment options include argon laser or yagphotocystostomy for small and PPV for large cysts.
(on line)
I am writing to express my deep gratitude to you for sending me in December, the latest issue of
Ophthalmology Update - Jan-March 2013, which I have just received. Quick look on the Journal have
shown me that I shall read the whole content with great interest as it happens always reading
Ophthalmology Update under your Editorship. With many thanks one more time, wishing you
continued fruitful work and prosperity. Warmest regards,